<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Adrenaline and vasopressin for cardiac arrest - Finn, J - 2019 | Cochrane Library</title> <meta content="Adrenaline and vasopressin for cardiac arrest - Finn, J - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003179.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Adrenaline and vasopressin for cardiac arrest - Finn, J - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003179.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003179.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Adrenaline and vasopressin for cardiac arrest" name="citation_title"/> <meta content="Judith Finn" name="citation_author"/> <meta content="judith.finn@curtin.edu.au" name="citation_author_email"/> <meta content="Ian Jacobs&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Teresa A Williams" name="citation_author"/> <meta content="Royal Perth Hospital" name="citation_author_institution"/> <meta content="Simon Gates" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="Gavin D Perkins" name="citation_author"/> <meta content="University of Warwick" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD003179.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/01/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003179.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003179.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003179.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Blood Circulation [*drug effects, physiology]; Epinephrine [*administration &amp; dosage]; Heart [drug effects]; Heart Arrest [*drug therapy, mortality, physiopathology]; Out‐of‐Hospital Cardiac Arrest [drug therapy, mortality]; Patient Admission [*statistics &amp; numerical data]; Patient Discharge [*statistics &amp; numerical data]; Placebos [administration &amp; dosage]; Randomized Controlled Trials as Topic; Survival Analysis; Vasoconstrictor Agents [*administration &amp; dosage]; Vasopressins [*administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003179.pub2&amp;doi=10.1002/14651858.CD003179.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003179\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003179\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003179.pub2",title:"Adrenaline and vasopressin for cardiac arrest",firstPublishedDate:"Jan 17, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003179.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003179.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003179.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003179.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003179.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003179.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003179.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003179.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003179.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003179.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14515 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003179.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0107"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-sec-0101"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/appendices#CD003179-sec-0112"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/table_n/CD003179StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/table_n/CD003179StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Adrenaline and vasopressin for cardiac arrest</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#CD003179-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Judith Finn</a></li> <li class="author custom-tooltip" title="Deceased"><a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#CD003179-cr-0003">Ian Jacobs</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#CD003179-cr-0004">Teresa A Williams</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#CD003179-cr-0005">Simon Gates</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information#CD003179-cr-0006">Gavin D Perkins</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information/en#CD003179-sec-0116">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 January 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003179.pub2">https://doi.org/10.1002/14651858.CD003179.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003179-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003179-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003179-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003179-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003179-abs-0001" lang="en"> <section id="CD003179-sec-0001"> <h3 class="title" id="CD003179-sec-0001">Background</h3> <p>Adrenaline and vasopressin are widely used to treat people with cardiac arrest, but there is uncertainty about the safety, effectiveness and the optimal dose. </p> </section> <section id="CD003179-sec-0002"> <h3 class="title" id="CD003179-sec-0002">Objectives</h3> <p>To determine whether adrenaline or vasopressin, or both, administered during cardiac arrest, afford any survival benefit. </p> </section> <section id="CD003179-sec-0003"> <h3 class="title" id="CD003179-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase and DARE from their inception to 8 May 2018, and the International Liaison Committee on Resuscitation 2015 Advanced Life Support Consensus on Science and Treatment Recommendations. We also searched four trial registers on 5 September 2018 and checked the reference lists of the included studies and review papers to identify potential papers for review. </p> </section> <section id="CD003179-sec-0004"> <h3 class="title" id="CD003179-sec-0004">Selection criteria</h3> <p>Any randomised controlled trial comparing: standard‐dose adrenaline versus placebo; standard‐dose adrenaline versus high‐dose adrenaline; and adrenaline versus vasopressin, in any setting, due to any cause of cardiac arrest, in adults and children. There were no language restrictions. </p> </section> <section id="CD003179-sec-0005"> <h3 class="title" id="CD003179-sec-0005">Data collection and analysis</h3> <p>Two review authors independently identified trials for review, assessed risks of bias and extracted data, resolving disagreements through re‐examination of the trial reports and by discussion. We used risk ratios (RRs) with 95% confidence intervals (CIs) to compare dichotomous outcomes for clinical events. There were no continuous outcomes reported. We examined groups of trials for heterogeneity. We report the quality of evidence for each outcome, using the GRADE approach. </p> </section> <section id="CD003179-sec-0006"> <h3 class="title" id="CD003179-sec-0006">Main results</h3> <p>We included 26 studies (21,704 participants).</p> <p>Moderate‐quality evidence found that adrenaline increased survival to hospital discharge compared to placebo (RR 1.44, 95% CI 1.11 to 1.86; 2 studies, 8538 participants; an increase from 23 to 32 per 1000, 95% CI 25 to 42). We are uncertain about survival to hospital discharge for high‐dose compared to standard‐dose adrenaline (RR 1.10, 95% CI 0.75 to 1.62; participants = 6274; studies = 10); an increase from 33 to 36 per 1000, 95% CI 24 to 53); standard‐dose adrenaline versus vasopressin (RR 1.25, 95% CI 0.84 to 1.85; 6 studies; 2511 participants; an increase from 72 to 90 per 1000, 95% CI 60 to 133); and standard‐dose adrenaline versus vasopressin plus adrenaline (RR 0.76, 95% CI 0.47 to 1.22; 3 studies; 3242 participants; a possible decrease from 24 to 18 per 1000, 95% CI 11 to 29), due to very low‐quality evidence. </p> <p>Moderate‐quality evidence found that adrenaline compared with placebo increased survival to hospital admission (RR 2.51, 95% CI 1.67 to 3.76; 2 studies, 8489 participants; an increase from 83 to 209 per 1000, 95% CI 139 to 313). We are uncertain about survival to hospital admission when comparing standard‐dose with high‐dose adrenaline, due to very low‐quality evidence. Vasopressin may improve survival to hospital admission when compared with standard‐dose adrenaline (RR 1.27, 95% CI 1.04 to 1.54; 3 studies, 1953 participants; low‐quality evidence; an increase from 260 to 330 per 1000, 95% CI 270 to 400), and may make little or no difference when compared to standard‐dose adrenaline plus vasopressin (RR 0.95, 95% CI 0.83 to 1.08; 3 studies; 3249 participants; low‐quality evidence; a decrease from 218 to 207 per 1000 (95% CI 181 to 236). </p> <p>There was no evidence that adrenaline (any dose) or vasopressin improved neurological outcomes. </p> <p>The rate of return of spontaneous circulation (ROSC) was higher for standard‐dose adrenaline versus placebo (RR 2.86, 95% CI 2.21 to 3.71; participants = 8663; studies = 3); moderate‐quality evidence; an increase from 115 to 329 per 1000, 95% CI 254 to 427). We are uncertain about the effect on ROSC for the comparison of standard‐dose versus high‐dose adrenaline and standard‐does adrenaline compared to vasopressin, due to very low‐quality evidence. Standard‐dose adrenaline may make little or no difference to ROSC when compared to standard‐dose adrenaline plus vasopressin (RR 0.97, 95% CI 0.87 to 1.08; 3 studies, 3249 participants; low‐quality evidence; a possible decrease from 299 to 290 per 1000, 95% CI 260 to 323). </p> <p>The source of funding was not stated in 11 of the 26 studies. The study drugs were provided by the manufacturer in four of the 26 studies, but neither drug represents a profitable commercial option. The other 11 studies were funded by organisations such as research foundations and government funding bodies. </p> </section> <section id="CD003179-sec-0007"> <h3 class="title" id="CD003179-sec-0007">Authors' conclusions</h3> <p>This review provides moderate‐quality evidence that standard‐dose adrenaline compared to placebo improves return of spontaneous circulation, survival to hospital admission and survival to hospital discharge, but low‐quality evidence that it did not affect survival with a favourable neurological outcome. Very low ‐quality evidence found that high‐dose adrenaline compared to standard‐dose adrenaline improved return of spontaneous circulation and survival to admission. Vasopressin compared to standard dose adrenaline improved survival to admission but not return of spontaneous circulation, whilst the combination of adrenaline and vasopressin compared with adrenaline alone had no effect on these outcomes. Neither standard dose adrenaline, high‐dose adrenaline,vasopressin nor a combination of adrenaline and vasopressin improved survival with a favourable neurological outcome. Many of these studies were conducted more than 20 years ago. Treatment has changed in recent years, so the findings from older studies may not reflect current practice. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003179-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003179-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003179-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003179-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003179-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003179-abs-0004" lang="en"> <h3>Adrenaline and vasopressin for cardiac arrest</h3> <p><b>Review question</b> </p> <p>Do the drugs adrenaline or vasopressin improve survival in cardiac arrest.</p> <p><b>Background</b> </p> <p>Cardiac arrest occurs when someone's heart unexpectedly stops beating. Without any treatment, death occurs within minutes. Treatments that are proven to work in cardiac arrest include cardiopulmonary resuscitation and giving an electric shock (defibrillation). If these treatments do not work, drugs such as adrenaline and vasopressin are injected (usually into a vein) to try to restart the heart. The early scientific evidence which led to their use came largely from small studies in animals. Whilst some human studies have shown that these drugs can help restart the heart initially, research also suggests they may have harmful effects on the brain. </p> <p><b>Search date</b> </p> <p>The last search was conducted on 8 May 2018.</p> <p><b>Study Characteristics</b> </p> <p>We identified 26 randomised controlled trials, involving 21,704 participants, that examined the effect of adrenaline or vasopressin on survival after cardiac arrest that occurred in and out of hospital and in adults and children. Some studies compared adrenaline in standard doses with placebo (dummy medication); some examined standard‐dose versus high‐dose adrenaline; and others compared vasopressin alone or vasopressin plus adrenaline to standard doses of adrenaline. </p> <p><b>Study funding sources</b> </p> <p>The source of funding was not stated in 11 of the 26 studies. The study drugs were provided by the manufacturer in four of the 26 studies, but neither drug represents a profitable commercial option. The other 11 studies were funded by organisations such as research foundations and government funding bodies. </p> <p><b>Key results</b> </p> <p>The studies found evidence that adrenaline was effective at restarting the heart and helping people recover enough to go home from hospital. However, there was no evidence that any of the drugs improved survival with a good neurological outcome. </p> <p><b>Quality of the evidence</b> </p> <p>The overall quality of evidence ranged from low to moderate (for studies comparing adrenaline to placebo), but mainly low or very low for the other comparisons, due to risks of bias within the studies. Many of these studies were conducted more than 20 years ago. Treatment has changed in recent years, so the findings from older studies may not reflect current practice. The studies examined the drugs in many different situations (in and outside of hospitals, at different dosages, and in both adults and children), which may make combining findings misleading. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003179-sec-0107" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-sec-0107">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-sec-0161">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003179-sec-0107"></div> <h3 class="title" id="CD003179-sec-0108">Implications for practice</h3> <section id="CD003179-sec-0108"> <p>Our review adds to the body of knowledge about the effect of vasopressors on survival and neurological outcomes from cardiac arrest. We included both adults and children, and we compared patient outcomes of in‐ and out‐of‐hospital cardiac arrests. However, most studies enrolled adult participants with out‐of‐hospital cardiac arrest, and this therefore limits the generalisability of our findings to in‐hospital cardiac arrest and to paediatric cardiac arrest. </p> <p>Compared to placebo, moderate‐quality evidence showed that standard‐dose adrenaline improved the return of spontaneous circulation, admission to hospital and survival to hospital discharge in people with out‐of‐hospital cardiac arrest. The effect on survival with a favourable neurological outcome at discharge is uncertain, as the evidence includes the possibility of benefit or harm. </p> <p>The evidence for high‐dose adrenaline compared to standard‐dose adrenaline was of very low quality, so we are uncertain of the effect on the return of spontaneous circulation, admission to hospital, survival to hospital discharge or survival with favourable neurological outcome. </p> <p>Low‐quality evidence showed that vasopressin compared to standard‐dose adrenaline improved only survival to hospital admission, with uncertainty about the effect on other outcomes, due to very low‐quality of evidence. </p> <p>Vasopressin and adrenaline compared to standard‐dose adrenaline alone (very low‐ and low‐quality evidence) showed no significant effects for any of the prespecified outcomes. </p> <p>Recommendations for the use of adrenaline should be informed by the findings of this review, taking into account the characteristics of the healthcare system (EMS and hospital facilities) and the values, preferences and priorities of the communities they serve. </p> </section> <h3 class="title" id="CD003179-sec-0109">Implications for research</h3> <section id="CD003179-sec-0109"> <p> <ul id="CD003179-list-0011"> <li> <p>We defined only limited subgroup analyses in our protocol, as we anticipated (and experienced) difficulty in extracting relevant subgroup data from the index studies. Future studies should seek to report sufficiently granular information on subgroups of participants, to enable a better understanding of treatment effects in different groups of participants. </p> </li> <li> <p>There is a paucity of research relating to in‐hospital cardiac arrest, and to in‐ and out‐of‐hospital cardiac arrest in children. </p> </li> <li> <p>Further research is required to better understand patients' prioritisation of outcomes following cardiac arrest, particularly their preferences about ‘trade‐offs’ between survival and neurological outcome </p> </li> <li> <p>Further research is required to identify interventions that can sustain the large increase in return of spontaneous circulation and survival to hospital admission through to survival to hospital discharge with favourable neurological outcomes. </p> </li> <li> <p>Further research on time to drug administration is required, since this may influence outcomes. </p> </li> <li> <p>The cost effectiveness of vasopressors as a treatment for cardiac arrest needs to be considered, especially in relation to the survivor’s long‐term quality of life. </p> </li> <li> <p>Investigation is needed about dosing and mode of administration of adrenaline, e.g. the use of lower doses of adrenaline or as a continuous effusion, targeting physiological measurements of organ perfusion. </p> </li> <li> <p>The implications of vasopressor use for cardiac arrest on the rates of organ donation need to be considered. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003179-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003179-sec-0029"></div> <div class="table" id="CD003179-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to placebo for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to placebo for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest <br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention:</b> standard‐dose adrenaline (SDA)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.44<br/> (1.11 to 1.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8538<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/> (25 to 42) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.51<br/> (1.67 to 3.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8489<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000<br/> (139 to 313) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.21<br/> (0.90 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8535<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes were defined as a CPC score of &lt; 3 or mRS &lt; 4</p> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (17 to 30) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.86<br/> (2.21 to 3.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8663<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>115 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>329 per 1000<br/> (254 to 427) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category; <b>mRs:</b> modified Rankin score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as one study at high risk of bias for incomplete outcome data </p> <p><sup>b</sup>Downgraded by one level for imprecision. The CI crosses the clinical decision threshold. </p> <p><sup>c</sup>Downgraded one level as two studies at high risk of bias for incomplete outcome data </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003179-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to high‐dose adrenaline (HDA) for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to high‐dose adrenaline (HDA) for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest<br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention:</b> High‐dose adrenaline (HDA)<br/> <b>Comparison:</b> Standard‐dose adrenaline (SDA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline (SDA)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with high‐dose adrenaline (HDA)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.10<br/> (0.75 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6274<br/> (10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Two more studies (N = 245) reported no survivors in either arm, but could not be added to the meta‐analysis due to zero events. </p> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>36 per 1000<br/> (24 to 53) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/> (1.03 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5764<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>213 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000<br/> (220 to 264) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.91<br/> (0.65 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5803<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,d,f,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes were defined as a CPC score of &lt; 3 in two studies; CPC &lt; 2 in one study and CPC &lt; 4 in one study. </p> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000<br/> (17 to 32) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.15<br/> (1.02 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7014<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>303 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>349 per 1000<br/> (309 to 391) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The funnel plots were slightly asymmetrical, so downgraded one level for possible publication bias.<br/> <sup>b</sup>Downgraded one level as five studies at high risk of bias.<br/> <sup>c</sup>Downgraded one level for inconsistency. Setting (in, out of hospital, emergency department) varies between studies. Variation in route of administration, doses and timing of dose administration between studies.<br/> <sup>d</sup>Downgraded one level for imprecision. Confidence interval includes possibility of clinically important harm or benefit.<br/> <sup>e</sup>Downgraded one level as three studies at high risk of bias.<br/> <sup>f</sup>Downgraded one level as two studies at high risk of bias.<br/> <sup>g</sup>Downgraded one level for inconsistency, due to substantial statistical heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003179-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to vasopressin for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to vasopressin for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest<br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention: V</b> asopressin<br/> <b>Comparison:</b> Standard‐dose adrenaline (SDA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vasopressin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25 (0.84 to 1.85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2511<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90 per 1000<br/> (60 to 133) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.27<br/> (1.04 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1953<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA (ED)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>260 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 per 1000<br/> (270 to 400) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.82<br/> (0.54 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2406<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes were defined as a CPC score of &lt; 3</p> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/> (21 to 49) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.10<br/> (0.90 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2531<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>311 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1000<br/> (280 to 413) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as two studies at high risk of bias.<br/> <sup>b</sup>Downgraded two levels for inconsistency. Studies included in‐ and out‐of‐hospital cardiac arrest and cardiac arrests in the emergency department. Inclusion criteria varied between studies, with inconsistencies in interventions given.<br/> <sup>c</sup>Downgraded two levels for imprecision. Events less than 300, upper and lower CI limits include both meaningful benefit and harm.<br/> <sup>d</sup>Downgraded one level for imprecision. Upper and lower CI limits include both meaningful benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003179-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to SDA plus vasopressin for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to SDA plus vasopressin for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest<br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention:</b> SDA plus vasopressin<br/> <b>Comparison:</b> Standard‐dose adrenaline (SDA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline (SDA)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with SDA plus vasopressin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.76<br/> (0.47 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3242<br/> (3 RCTs)<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000<br/> (11 to 29) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.83 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3249<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>218 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>207 per 1000<br/> (181 to 236) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.65<br/> (0.33 to 1.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2887<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes was defined as a CPC score of &lt; 3</p> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9per 1000<br/> (5 to 18) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.87 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3249<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>299 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000<br/> (260 to 323) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision. Event rate less than 300 and confidence interval includes possibility of clinically important harm or benefit.<br/> <sup>b</sup>Downgraded one level for inconsistency. Setting (in, out of hospital, emergency department) varies between studies. Variation in route of administration, doses and timing of dose administration between studies.<br/> <sup>c</sup>Downgraded one level for imprecision. Confidence interval includes possibility of clinically important harm or benefit. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003179-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-sec-0125">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD003179-sec-0030"></div> <section id="CD003179-sec-0031"> <h3 class="title" id="CD003179-sec-0031">Description of the condition</h3> <p>Sudden cardiac arrest is defined by the absence of signs of circulation (<a href="./references#CD003179-bbs2-0127" title="PerkinsGD , JacobsIG , NadkarniVM , BergRA , BhanjiF , BiarentD , et al. Utstein Collaborators. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update of the Utstein Resuscitation Registry Templates for Out‐of‐Hospital Cardiac Arrest: a statement for healthcare professionals from a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Resuscitation2015;96:328‐40. [PUBMED: 25438254] ">Utstein 2015</a>). Each year, globally, hundreds of thousands of people sustain a cardiac arrest from which fewer then one in ten survive if the arrest occurs outside a hospital (<a href="./references#CD003179-bbs2-0078" title="BeckB , BrayJ , CameronP , SmithK , WalkerT , GranthamH , et al. Regional variation in the characteristics, incidence and outcomes of out‐of‐hospital cardiac arrest in Australia and New Zealand: results from the Aus‐ROC Epistry. Resuscitation2018;126:49‐57. ">Beck 2018</a>; <a href="./references#CD003179-bbs2-0083" title="DayaMR , SchmickerRH , ZiveDM , ReaTD , NicholG , BuickJE , et al. Out‐of‐hospital cardiac arrest survival improving over time: results from the Resuscitation Outcomes Consortium (ROC). Resuscitation2015; Vol. 91:108‐15. ">Daya 2015</a>; <a href="./references#CD003179-bbs2-0085" title="GräsnerJT , LeferingR , KosterRW , MastersonS , BöttigerBW , HerlitzJ , et al. EuReCa ONE‐27 Nations, ONE Europe, ONE Registry: a prospective one month analysis of out‐of‐hospital cardiac arrest outcomes in 27 countries in Europe. Resuscitation2016; Vol. 105:188‐95. ">Grasner 2016</a>; <a href="./references#CD003179-bbs2-0112" title="SongKJ , KoPC , LeongBS , KhunkhlaiN , NarooGY , SarahA , et al. Outcomes for out‐of‐hospital cardiac arrests across 7 countries in Asia: the Pan Asian Resuscitation Outcomes Study (PAROS). Resuscitation2015;96:100‐8. ">PAROS 2015</a>) and around one in five if the arrest occurs inside a hospital (<a href="./references#CD003179-bbs2-0084" title="GirotraS , CramP , SpertusJA , NallamothuBK , LiY , JonesPG , et al. Hospital variation in survival trends for in‐hospital cardiac arrest. Journal of the American Heart Association2014; Vol. 3, issue 3:e000871. ">Girotra 2014</a>; <a href="./references#CD003179-bbs2-0108" title="NolanJP , SoarJ , SmithGB , GwinnuttC , ParrottF , PowerS , et al. Incidence and outcome of in‐hospital cardiac arrest in the United Kingdom National Cardiac Arrest Audit. Resuscitation2014; Vol. 85, issue 8:987‐82. ">Nolan 2014</a>). Key treatments associated with survival are high‐quality cardiopulmonary resuscitation (CPR) (<a href="./references#CD003179-bbs2-0086" title="Hasselqvist‐AxI , RivaG , HerlitzJ , RosenqvistM , HollenbergJ , NordbergP , et al. Early cardiopulmonary resuscitation in out‐of‐hospital cardiac arrest. New England Journal of Medicine2015; Vol. 372, issue 24:2307‐15. ">Hasselqvist‐Ax 2015</a>; <a href="./references#CD003179-bbs2-0119" title="SassonC , RogersMA , DahlJ , KellermannAL . Predictors of survival from out‐of‐hospital cardiac arrest: a systematic review and meta‐analysis. Circulation. Cardiovascular Quality and Outcomes2010;3(1):63‐81. ">Sasson 2010</a>; <a href="./references#CD003179-bbs2-0130" title="WikL , OlsenJA , PersseD , SterzF , LozanoMJr , BrouwerMA , et al. Why do some studies find that CPR fraction is not a predictor of survival?. Resuscitation2016;104:59‐62. ">Wik 2016</a>) and early defibrillation (<a href="./references#CD003179-bbs2-0118" title="SandroniC , NolanJ , CavallaroF , AntonelliM . In‐hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Medicine2007;33(2):237‐45. ">Sandroni 2007</a>; <a href="./references#CD003179-bbs2-0119" title="SassonC , RogersMA , DahlJ , KellermannAL . Predictors of survival from out‐of‐hospital cardiac arrest: a systematic review and meta‐analysis. Circulation. Cardiovascular Quality and Outcomes2010;3(1):63‐81. ">Sasson 2010</a>). </p> <p>The initial goal of resuscitation is to restart the heart, described as achieving return of spontaneous circulation (ROSC). However amongst those people in whom ROSC is achieved, only about 25% to 50% survive to go home from hospital. The main causes of hospital deaths are severe brain injury and multi‐organ failure (<a href="./references#CD003179-bbs2-0095" title="LaverS , FarrowC , TurnerD , NolanJ . Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Medicine2004;30(11):2126‐8. [PUBMED: 15365608] ">Laver 2004</a>). Thus overall survival rates to hospital discharge are low, in the range of 0.6% to 25% (<a href="./references#CD003179-bbs2-0080" title="BerdowskiJ , BergRA , TijssenJG , KosterRW . Global incidences of out‐of‐hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation2010;81(11):1479‐87. ">Berdowski 2010</a>). </p> <p>A significant proportion of those who survive to leave hospital are left with significant brain damage (<a href="./references#CD003179-bbs2-0082" title="CorradaE , MennuniMG , GriecoN , SesanaG , BerettaG , PresbiteroP . Neurological recovery after out‐of‐hospital cardiac arrest: hospital admission predictors and one‐year survival in an urban cardiac network experience. Minerva Cardioangiologica2013;61(4):451‐60. [PUBMED: 23846011] ">Corrada 2013</a>; <a href="./references#CD003179-bbs2-0092" title="KimYJ , AhnS , SohnCH , SeoDW , LeeYS , LeeJH , et al. Long‐term neurological outcomes in patients after out‐of‐hospital cardiac arrest. Resuscitation2016;101:1‐5. [PUBMED: 26826564] ">Kim 2016</a>; <a href="./references#CD003179-bbs2-0120" title="ScalesDC , GolanE , PintoR , BrooksSC , ChapmanM , DaleCM , et al. Improving appropriate neurological prognostication after cardiac arrest: a stepped wedge cluster RCT. American Journal of Respiratory and Critical Care Medicine2016;194(9):1083‐91. [PUBMED: 27115286] ">Scales 2016</a>). Even those with apparently good overall recovery may be left with subtle cognitive impairment (<a href="./references#CD003179-bbs2-0109" title="NolanJP , SoarJ , CariouA , CronbergT , MoulaertVR , DeakinCD , et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines for post‐resuscitation care 2015: section 5 of the European Resuscitation Council guidelines for resuscitation 2015. Resuscitation2015;95:202‐22. [PUBMED: 26477702] ">Nolan 2015a</a>). </p> </section> <section id="CD003179-sec-0032"> <h3 class="title" id="CD003179-sec-0032">Description of the intervention</h3> <p>Pharmacological agents were a central part of early resuscitation algorithms, but the evidence for whether or not they are effective has been questioned for nearly two decades (<a href="./references#CD003179-bbs2-0102" title="LundinA , DjärvT , EngdahlJ , HollenbergJ , NordbergP , Ravn‐FischerA , et al. Drug therapy in cardiac arrest: a review of the literature. European Heart Journal: Cardiovascular Pharmacotherapy2016; Vol. 2, issue 1:54‐75. ">Lundin 2016</a>; <a href="./references#CD003179-bbs2-0106" title="NolanJP , DeLatorreFJ , SteenPA , ChamberlainDA , BossaertLL . Advanced life support drugs: do they really work?. Current Opinion in Critical Care2002; Vol. 8, issue 3:212‐8. ">Nolan 2002</a>; <a href="./references#CD003179-bbs2-0113" title="PerkinsGD , CottrellP , GatesS . Is adrenaline safe and effective as a treatment for out of hospital cardiac arrest?. BMJ2014;348:g2435. ">Perkins 2014</a>). Adrenaline has been used over a range of doses (0.5 mg to more than 10 mg) through intracardiac, intravenous, endobronchial and intraosseous routes. </p> <p>Vasopressin was explored as an adjunct or alternative to adrenaline in the late 1990s. Early experimental and animal studies suggested that vasopressin was superior to adrenaline, particularly during prolonged resuscitation (<a href="./references#CD003179-bbs2-0128" title="WenzelV , LindnerKH , KrismerAC , VoelckelWG , SchockeMF , HundW , et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. Journal of the American College of Cardiology2000;35(2):527‐33. ">Wenzel 2000</a>). However, evaluation in subsequent randomised controlled trials in humans produced equivocal results (<a href="./references#CD003179-bbs2-0096" title="LayekA , MaitraS , PalS , BhattacharjeeS , BaidyaDK . Efficacy of vasopressin during cardio‐pulmonary resuscitation in adult patients: a meta‐analysis. Resuscitation2014; Vol. 85:853‐63. ">Layek 2014</a>). Vasopressin was recommended in American Heart Association guidelines from 2000 through to 2015, when its routine use was no longer recommended (<a href="./references#CD003179-bbs2-0100" title="LinkMS , BerkowLC , KudenchukPJ , HalperinHR , HessEP , MoitraVK , et al. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation2015; Vol. 132:s444‐64. ">Link 2015</a>). </p> </section> <section id="CD003179-sec-0033"> <h3 class="title" id="CD003179-sec-0033">How the intervention might work</h3> <p>The proposed mechanism of action for adrenaline in cardiac arrest has been described previously (<a href="./references#CD003179-bbs2-0107" title="NolanJP , PerkinsGD . Is there a role for adrenaline during cardiopulmonary resuscitation?. Current Opinion in Critical Care2013;19(3):169‐74. [PUBMED: 23628783] ">Nolan 2013</a>). Stimulation of α‐receptors located on vascular smooth muscle causes vasoconstriction which increases aortic diastolic pressure and coronary perfusion pressure, which optimises the chances of achieving return of spontaneous circulation (ROSC) (<a href="./references#CD003179-bbs2-0111" title="ParadisNA , MartinGB , RiversEP , GoettingMG , AppletonTJ , FeingoldM , et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA1990;263(8):1106‐13. ">Paradis 1990</a>). Potentially harmful effects arise from deleterious changes in cerebral microvascular blood flow leading to worsening of cerebral injury (<a href="./references#CD003179-bbs2-0081" title="BurnettAM , SegalN , SalzmanJG , McKniteMS , FrasconeRJ . Potential negative effects of epinephrine on carotid blood flow and ETCO2 during active compression‐decompression CPR utilizing an impedance threshold device. Resuscitation2012;83(8):1021‐4. [PUBMED: 22445865] ">Burnett 2012</a>; <a href="./references#CD003179-bbs2-0117" title="RistagnoG , TangW , HuangL , FymatA , ChangYT , SunS , et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Critical Care Medicine2009;37(4):1408‐15. ">Ristagno 2009</a>), increased cardiac instability after ROSC and adverse metabolic and immunomodulatory effects (<a href="./references#CD003179-bbs2-0107" title="NolanJP , PerkinsGD . Is there a role for adrenaline during cardiopulmonary resuscitation?. Current Opinion in Critical Care2013;19(3):169‐74. [PUBMED: 23628783] ">Nolan 2013</a>; <a href="./references#CD003179-bbs2-0129" title="WiedermannFJ , StichlbergerM , LedererW . Is epinephrine during cardiac arrest associated with worse outcomes in resuscitated patients? Effect of vasopressin and catecholamines on the migration of leukocytes. Critical Care2015; Vol. 19:120. [PUBMED: 25881048] ">Wiedermann 2015</a>). The potentially deleterious effects of adrenaline led to the search for alternative vasopressors. Vasopressin is a naturally‐occurring antidiuretic hormone. In high doses it acts as a potent vasoconstrictor via V1a receptors located on smooth muscle cells, resulting in increased systemic vascular resistance which raises coronary perfusion pressure (<a href="./references#CD003179-bbs2-0099" title="LindnerKH , PrengelAW , PfenningerEG , LindnerIM , StrohmengerHU , GeorgieffM , et al. Vasopressin improves vital organ blood flow during closed‐chest cardiopulmonary resuscitation in pigs. Circulation1995;91(1):215‐21. ">Lindner 1995</a>). Previous laboratory data suggest that vasopressin is superior to adrenaline in improving vital organ perfusion during CPR, post‐ROSC survival leading to better neurological outcome (<a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a>). </p> </section> <section id="CD003179-sec-0034"> <h3 class="title" id="CD003179-sec-0034">Why it is important to do this review</h3> <p>Observational studies allow large amounts of data to be collected but are often limited by bias and confounding. Statistical techniques can be used to adjust for differences in measured confounding variables, but unknown confounders may still lead to biased results. </p> <p>An early evaluation of the effect of vasopressors for cardiac arrest was presented by the Ontario Prehospital Advanced Life Support (OPALS) group. This prospective, observational study tested the incremental effect on the rate of survival after out‐of‐hospital cardiac arrest of adding a programme of advanced life support (ALS, endotracheal intubation and intravenous drugs) to a programme of rapid defibrillation in the late 1990s. The ALS interventions produced no increase in survival (odds ratio (OR) 1.1, 95% confidence interval (CI) 0.8 to 1.5), raising uncertainty about the role of drugs and advanced airway management in cardiac arrest. (<a href="./references#CD003179-bbs2-0124" title="StiellIG , WellsGA , FieldB , SpaiteDW , NesbittLP , DeMaioVJ , et al. Advanced cardiac life support in out‐of‐hospital cardiac arrest. New England Journal of Medicine2004; Vol. 351, issue 7:647‐56. ">Stiell 2004</a>). </p> <p>One of the first large prospective evaluations to raise concern about adrenaline in cardiac arrest was a propensity‐matched observational study from Japan (<a href="./references#CD003179-bbs2-0041" title="HagiharaA , HasegawaM , AbeT , NagataT , WakataY , MiyazakiS . Prehospital epinephrine use and survival among patients with out‐of‐hospital cardiac arrest. JAMA2012;307(11):1161‐8. ">Hagihara 2012</a>), which enrolled 417,188 participants with out‐of‐hospital cardiac arrest. The study found that those who received adrenaline had improved rates of return of spontaneous circulation (adjusted (Adj) OR 2.51, 95% CI 2.24 to 2.80), but fewer participants were alive at 30 days (Adj OR 0.54, 95% CI 0.43 to 0.68) and the neurological outcome was worse (Adj OR 0.21, 95% CI 0.10 to 0.44) (<a href="./references#CD003179-bbs2-0041" title="HagiharaA , HasegawaM , AbeT , NagataT , WakataY , MiyazakiS . Prehospital epinephrine use and survival among patients with out‐of‐hospital cardiac arrest. JAMA2012;307(11):1161‐8. ">Hagihara 2012</a>). The effect of unmeasured confounders and the challenges this presents in interpreting observational studies is highlighted by a subsequent analysis (<a href="./references#CD003179-bbs2-0105" title="NakaharaS , TomioJ , TakahashiH , IchikawaM , NishidaM , MorimuraN , et al. Evaluation of pre‐hospital administration of adrenaline (epinephrine) by emergency medical services for patients with out of hospital cardiac arrest in Japan: controlled propensity matched retrospective cohort study. BMJ2013; Vol. 347:f6829. ">Nakahara 2013</a>). In this study researchers used a different propensity‐matched scoring algorithm to analyse data from the same registry used by <a href="./references#CD003179-bbs2-0041" title="HagiharaA , HasegawaM , AbeT , NagataT , WakataY , MiyazakiS . Prehospital epinephrine use and survival among patients with out‐of‐hospital cardiac arrest. JAMA2012;307(11):1161‐8. ">Hagihara 2012</a>, which mitigated the signal of harm shown by <a href="./references#CD003179-bbs2-0041" title="HagiharaA , HasegawaM , AbeT , NagataT , WakataY , MiyazakiS . Prehospital epinephrine use and survival among patients with out‐of‐hospital cardiac arrest. JAMA2012;307(11):1161‐8. ">Hagihara 2012</a> and suggested marginally better outcomes in participants with non‐shockable rhythms<i>(</i><a href="./references#CD003179-bbs2-0105" title="NakaharaS , TomioJ , TakahashiH , IchikawaM , NishidaM , MorimuraN , et al. Evaluation of pre‐hospital administration of adrenaline (epinephrine) by emergency medical services for patients with out of hospital cardiac arrest in Japan: controlled propensity matched retrospective cohort study. BMJ2013; Vol. 347:f6829. ">Nakahara 2013</a>). This may explain in part the high levels of heterogeneity noted in meta‐analyses of observational studies of vasopressors in cardiac arrest (<a href="./references#CD003179-bbs2-0101" title="LoombaRS , NijhawanK , AggarwalS , AroraRR . Increased return of spontaneous circulation at the expense of neurologic outcomes: Is prehospital epinephrine for out‐of‐hospital cardiac arrest really worth it?. Journal of Critical Care2015; Vol. 30, issue 6:1376‐81. ">Loomba 2015</a>). </p> <p>Vasoactive drugs have been an established treatment for cardiac arrest throughout the world, even though there was no evidence that they were beneficial for long‐term outcomes (<a href="./references#CD003179-bbs2-0110" title="NolanJP , HazinskiMF , AickinR , BhanjiF , BilliJE , CallawayCW , et al. Part 1: executive summary: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation2015;95:e1‐31. [PUBMED: 26477703] ">Nolan 2015b</a>). Recent evidence from observational studies shows a consistent pattern of benefit on short‐term outcomes (return of spontaneous circulation and survival to hospital admission), but a reduction in survival to hospital discharge and the proportion of participants surviving with a favourable neurological outcome (<a href="./references#CD003179-bbs2-0113" title="PerkinsGD , CottrellP , GatesS . Is adrenaline safe and effective as a treatment for out of hospital cardiac arrest?. BMJ2014;348:g2435. ">Perkins 2014</a>). However, such studies are limited by unmeasured confounders, not least the fact that those with the best prognosis (i.e. with a rapid return of spontaneous circulation after defibrillation or other resuscitation measures) are less likely to receive adrenaline. </p> <p>In 2015 the International Liaison Committee on Resuscitation (ILCOR) synthesised the available evidence and concluded that there is insufficient evidence to know if adrenaline or other vasoactive drugs had beneficial or harmful effects on survival to discharge from hospital and on neurological outcome (<a href="./references#CD003179-bbs2-0110" title="NolanJP , HazinskiMF , AickinR , BhanjiF , BilliJE , CallawayCW , et al. Part 1: executive summary: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation2015;95:e1‐31. [PUBMED: 26477703] ">Nolan 2015b</a>). ILCOR called for placebo‐controlled trials to evaluate the use of any vasopressor in adult and paediatric cardiac arrest (<a href="./references#CD003179-bbs2-0093" title="KleinmanME , PerkinsGD , BhanjiF , BilliJE , BrayJE , CallawayCW , et al. ILCOR scientific knowledge gaps and clinical research priorities for cardiopulmonary resuscitation and emergency cardiovascular care: a consensus statement. Resuscitation2018;127:132‐46. ">Kleinman 2018</a>). </p> <p>Against this background, we set out to complete a comprehensive review of randomised controlled trials examining the effectiveness of vasoactive drugs during the resuscitation of adults and children in cardiac arrest. This review considers and pools evidence from randomised controlled trials of the two most commonly used vasoactive drugs (adrenaline and vasopressin) and considers the effect of drug dose and whether they work best singly or in combination. It extends previous systematic reviews through rigorous assessment of bias, by focusing only on randomised controlled trials, including adult and paediatric studies and from both an out‐of‐hospital and in‐hospital settings (<a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a>; <a href="./references#CD003179-bbs2-0123" title="SoarJ , CallawayCW , AibikiM , BottigerBW , BrooksSC , DeakinCD , et al. Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation2015;95:e71‐120. [PUBMED: 26477429] ">Soar 2015</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003179-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-sec-0130">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003179-sec-0035"></div> <p>To determine whether adrenaline or vasopressin or both, administered during a cardiac arrest, afford any survival benefit. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003179-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-sec-0131">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003179-sec-0036"></div> <section id="CD003179-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003179-sec-0038"> <h4 class="title">Types of studies</h4> <p>Any randomised controlled trial comparing (1) standard‐dose (or high‐dose) adrenaline versus placebo; (2) standard‐dose adrenaline versus high‐dose adrenaline; or (3) adrenaline versus vasopressin (alone or in combination with adrenaline). We include non‐English articles (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>), conference abstracts (<a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) and letters to the editor of peer‐reviewed journals (<a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>) in this review. We exclude animal studies. We include data from all papers for the same study population as one study, e.g. <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>. </p> </section> <section id="CD003179-sec-0039"> <h4 class="title">Types of participants</h4> <p>We include all participants of any age suffering cardiac arrest from any cause. Trials could enrol participants suffering cardiac arrest either outside of hospital (OHCA) or during hospitalisation (IHCA). </p> </section> <section id="CD003179-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We include trials that compared intravenous adrenaline versus placebo, high‐dose adrenaline or vasopressin. Optimal administration of adrenaline is intravenous (IV), with a free‐flowing saline infusion, although flushing intravenous lines with 20 to 30 mls of IV fluid is commonly practised. We also include the intra‐osseous route. We accepted adrenaline administered by an endotracheal tube, although this demonstrates different pharmacodynamic and pharmacokinetic properties. Intracardiac adrenaline administration has essentially been abandoned for more than a decade, and we do not include it in this review. The comparisons of interest were: </p> <p> <ul id="CD003179-list-0001"> <li> <p>Standard‐dose adrenaline versus placebo</p> </li> <li> <p>Standard‐dose adrenaline versus high‐dose adrenaline</p> </li> <li> <p>Standard‐dose adrenaline versus vasopressin</p> </li> <li> <p>Standard‐dose adrenaline versus vasopressin plus adrenaline</p> </li> </ul> </p> <p>The standard dosages of adrenaline and vasopressin that are commonly used in clinical studies are 1 mg and 40 IU, respectively. </p> </section> <section id="CD003179-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD003179-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>We initially proposed the following outcomes, but we have not covered the last three in the results of this review because they were rarely reported in the included studies. </p> <p> <ul id="CD003179-list-0002"> <li> <p>Survival to hospital discharge.</p> </li> <li> <p>Survival to hospital admission.</p> </li> <li> <p>Neurological outcome, assessed using either the Glasgow Outcome Scale (<a href="./references#CD003179-bbs2-0091" title="JennettB , BondM . Assessment of outcome after severe brain damage. Lancet1975;1(7905):480‐4. ">Jennett 1975</a>; <a href="./references#CD003179-bbs2-0125" title="TeasdaleGM , PettigrewLE , WilsonJT , MurrayG , JennettB . Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. Journal of Neurotrauma1998;15(8):587‐97. ">Teasdale 1998</a>) or Cerebral Performance Category (<a href="./references#CD003179-bbs2-0091" title="JennettB , BondM . Assessment of outcome after severe brain damage. Lancet1975;1(7905):480‐4. ">Jennett 1975</a>) or modified Rankin scale (<a href="./references#CD003179-bbs2-0115" title="QuinnTJ , DawsonJ , WaltersMR , LeesKR . Exploring the reliability of the modified rankin scale. Stroke2009;40(3):762‐6. ">Quinn 2009</a>). </p> </li> </ul> </p> </section> <section id="CD003179-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003179-list-0003"> <li> <p>Return of spontaneous circulation (ROSC)</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Return of non‐perfusing cardiac rhythm</p> </li> <li> <p>Admission to intensive care unit (ICU) (not reported)</p> </li> </ul> </p> </section> </section> </section> <section id="CD003179-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003179-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases from their inception to 8 May 2018, using the MeSH and text terms shown in <a href="./appendices#CD003179-sec-0113">Appendix 1</a>: </p> <p> <ul id="CD003179-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), Issue 4 of 12, 2018 (Cochrane Library) </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE), Issue 2 of 4, 2015 (Cochrane Library) (No longer updated) </p> </li> <li> <p>Epub Ahead of Print, In‐Process and Other Non‐Indexed Citations, MEDLINE Daily and MEDLINE (Ovid, 1946 to 08 May 2018) </p> </li> <li> <p>Embase Classic and Embase (Ovid, 1947 to 2018 May 07)</p> </li> </ul> </p> <p>The RCT filter for MEDLINE is the Cochrane sensitivity‐maximising RCT filter. For Embase, we applied the terms as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003179-bbs2-0097" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). </p> </section> <section id="CD003179-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all included studies and relevant systematic reviews (e.g. <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>), for additional references to randomised trials. </p> <p>We also searched the International Liaison Committee on Resuscitation (ILCOR) 2015 Advanced Life Support Consensus on Science and Treatment Recommendations (CoSTR) (<a href="./references#CD003179-bbs2-0123" title="SoarJ , CallawayCW , AibikiM , BottigerBW , BrooksSC , DeakinCD , et al. Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation2015;95:e71‐120. [PUBMED: 26477429] ">Soar 2015</a>). </p> <p>We searched for ongoing trials on 5 September 2018, using various combinations of keywords such as 'adrenaline, epinephrine, vasopressin, cardiac arrest, heart arrest, resuscitation', on the following trials registers: </p> <p> <ul id="CD003179-list-0005"> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>International standardised randomised controlled trials number (ISRCTN) registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>). </p> </li> <li> <p>NHS Clinical Trials and Medical Research (<a href="http://www.nhs.uk/Conditions/Clinical-trials/Pages/clinical-trial-details.aspx?TrialId=" target="_blank">www.nhs.uk/Conditions/Clinical‐trials/Pages/clinical‐trial‐details.aspx?TrialId=</a> ). </p> </li> </ul> </p> </section> </section> <section id="CD003179-sec-0047"> <h3 class="title" id="CD003179-sec-0047">Data collection and analysis</h3> <section id="CD003179-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (JF and IJ initially; JF and TW in subsequent searches) independently read the titles and abstracts of relevant papers retrieved by the search strategy described above, to identify potentially suitable studies. If in doubt about whether a title was relevant, we read the full article. We retrieved full publications of all potentially‐relevant studies and stored them electronically in an Endnote library. Two review authors (TW and JF) determined trial eligibility independently, using a standardised inclusion form, and excluding studies that did not meet the inclusion criteria. We did not apply any language restrictions. We resolved any disagreements by discussion with the other two review authors (GP and SG). We detail the excluded studies and reasons for their exclusion in the <a href="./references#CD003179-sec-0123" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD003179-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>We recorded data initially on paper, and then on electronic data extraction forms (which we had piloted) and entered them into Review Manager 5. We recorded all clinically relevant outcomes, including adverse events. We resolved differences through re‐examination of the study report and further discussion, consulting with a third review author (IJ/GP) if we could not achieve consensus. </p> <p>We sought the following data items from each study:</p> <p>Study characteristics </p> <p> <ul id="CD003179-list-0006"> <li> <p>Location of study</p> </li> <li> <p>In‐hospital cardiac arrest (IHCA) or out‐of‐hospital cardiac arrest (OHCA), or both</p> </li> <li> <p>Type of emergency medical system (EMS) (OHCA)</p> </li> <li> <p>Study design: RCT or quasi‐RCT</p> </li> <li> <p>Blinding</p> </li> </ul> </p> <p>Participant characteristics in each arm of the study </p> <p> <ul id="CD003179-list-0007"> <li> <p>Age (mean, standard deviation (SD), range)</p> </li> <li> <p>Male %</p> </li> <li> <p>Ventricular fibrillation (VF)/ventricular tachycardia (VT) %</p> </li> <li> <p>Witnessed (OHCA) %</p> </li> <li> <p>Cardiac aetiology %</p> </li> <li> <p>EMS witnessed (OHCA) %</p> </li> <li> <p>Bystander cardiopulmonary resuscitation (CPR) (OHCA)%</p> </li> <li> <p>Initial rhythm %</p> </li> <li> <p>Study inclusion/exclusion criteria</p> </li> </ul> </p> <p>Number of participants in each study arm </p> <p> <ul id="CD003179-list-0008"> <li> <p>Number eligible</p> </li> <li> <p>Excluded pre‐randomisation</p> </li> <li> <p>Numbers randomised</p> </li> <li> <p>Lost to follow‐up</p> </li> <li> <p>Number analysed</p> </li> </ul> </p> <p>Details of intervention/comparison groups </p> <p> <ul id="CD003179-list-0009"> <li> <p>Study drug, control ‘drug’, dose, route, frequency, maximum dose, time frames</p> </li> <li> <p>Other interventions, e.g. IV flushing agent</p> </li> <li> <p>Other specific protocols for resuscitation</p> </li> </ul> </p> <p>Outcomes: </p> <p> <ul id="CD003179-list-0010"> <li> <p>Event numbers and denominator numbers for each study arm</p> </li> <li> <p>Return of spontaneous circulation (ROSC)</p> </li> <li> <p>Survival to hospital admission (OHCA only)</p> </li> <li> <p>Admission to ICU</p> </li> <li> <p>Discharged from hospital alive (or in‐hospital mortality)</p> </li> <li> <p>Neurological outcome on discharge from hospital (and tool used to measure)</p> </li> </ul> </p> <p>One of the included studies was only available in Chinese. The data extraction for this paper was undertaken by a translator (native Chinese speaker), and the data were double‐checked against the English abstract (TW and JF). </p> </section> <section id="CD003179-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (TW, JF) independently assessed risks of bias, using the Cochrane 'Risk of bias' tool. This involves judgements across a series of domains of bias, as described in Chapter 8 of the <i>Cochrane Handbook</i> (<a href="./references#CD003179-bbs2-0089" title="HigginsJP , AltmanDG , SterneJAC , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). </p> <p>Three independent investigators (TW, GDP and SG) reviewed papers co‐authored by authors of this systematic review (e.g. <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>), using the criteria recommended by the Cochrane Heart Group. Similarly, TW (who was not a co‐investigator on the study or a co‐author of the paper) assessed risks of bias for the <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> study. </p> </section> <section id="CD003179-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We used risk ratios (RRs) with 95% confidence intervals (CIs) to compare dichotomous outcomes. We had planned to analyse continuous outcomes as mean differences (MDs), but none were reported. We dichotomised neurological outcomes reported as Cerebral Performance Category (<a href="./references#CD003179-bbs2-0091" title="JennettB , BondM . Assessment of outcome after severe brain damage. Lancet1975;1(7905):480‐4. ">Jennett 1975</a>) scores (1 to 5) as follows: 1 ‐ 2 ‘good’ neurological outcome and 3 ‐ 5 ’poor’ neurological outcome. Similarly, we rated a score of 3 or less on the modified Rankin scale, (<a href="./references#CD003179-bbs2-0115" title="QuinnTJ , DawsonJ , WaltersMR , LeesKR . Exploring the reliability of the modified rankin scale. Stroke2009;40(3):762‐6. ">Quinn 2009</a>), which ranges from 0 (no symptoms) to 6 (death), as a 'favourable' neurologic outcome. </p> </section> <section id="CD003179-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>Whilst there was a potential problem with including five multi‐arm studies (<a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>), we avoided an issue with unit of analysis by treating each dose as a separate analysis, so that the same control group was not used twice within the same analysis. </p> </section> <section id="CD003179-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We made no attempt to impute missing data values. We tried to contact the authors of <a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a> but there was no reply. We did not attempt to contact other trial authors to identify missing data because many of the studies are quite old. </p> </section> <section id="CD003179-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined groups of trials for clinical and statistical heterogeneity; the former involved assessment of whether we judged the participants, interventions, comparisons and outcomes to be sufficiently similar to ensure an answer that is clinically meaningful, while the latter involved the use of the Chi<sup>2</sup> and I<sup>2</sup> statistics and visual inspection of the forest plots. As in the <i>Cochrane Handbook</i> (Chapter 9) (<a href="./references#CD003179-bbs2-0089" title="HigginsJP , AltmanDG , SterneJAC , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>), we consider an I<sup>2</sup> statistic greater than 50% to represent substantial heterogeneity. </p> </section> <section id="CD003179-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>To establish the potential influence of small‐trial effects and possible publication bias, we constructed funnel plots for each outcome where we had included more than 10 studies in the meta‐analysis. </p> </section> <section id="CD003179-sec-0056"> <h4 class="title">Data synthesis</h4> <p>Where we deemed clinical and statistical heterogeneity to be acceptable, we conducted meta‐analyses using Review Manager 5 to combine results for each outcome across studies. We used a random‐effects model to calculate a weighted average of Mantel–Haenszel risk ratios across studies for all outcomes. We did not assume that all studies measured the same underlying true effect (i.e. fixed‐effect across studies). </p> </section> <section id="CD003179-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The a priori subgroup analyses were: (1) adult participants and paediatric participants; (2) OHCA and IHCA events. Both are considered potential effect modifiers, due to known differences in cardiac arrest aetiology in the subgroups. </p> </section> <section id="CD003179-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>To determine whether the findings of the systematic review were influenced by specific studies, we performed sensitivity analyses restricting the analysis to a subset of the studies, by excluding those at high risk of bias (as shown in red in Figure 2) in any domain. </p> <p>We performed sensitivity analyses for the following comparisons: (1) high‐dose versus standard‐dose adrenaline; (2) vasopressin versus vasopressin plus adrenaline. </p> <section id="CD003179-sec-0059"> <h5 class="title">‘Summary of findings’ tables</h5> <p>We used the GRADE approach (<a href="http://www.gradepro.org/" target="_blank">www.gradepro.org</a> ) to construct a ‘Summary of findings’ table for each outcome for the primary comparison, where possible. The five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) are used to assess the quality of the body of evidence for each outcome. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003179-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003179-sec-0060"></div> <section id="CD003179-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD003179-sec-0062"> <h4 class="title">Results of the search</h4> <p>The search found 2056 papers, reduced to 1808 after de‐duplication. We excluded 1730 of these on the basis of title and abstract not meeting the study criteria. A recently published RCT (<a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>) of SDE versus placebo was included. We also identified: a potential study (<a href="./references#CD003179-bbs2-0039" title="GhafourianN , ManiaeNH , TaherikalaniM , MehraziM , HossieniM , ValianF , et al. Combination of vasopressin ‐ epinephrine as a novel candidate in patients with cardiac arrest. Recent Advances in Cardiovascular Drug Discovery2015;10(1):65‐9. ">Ghafourian 2015</a>) from a recent systematic review (<a href="./references#CD003179-bbs2-0079" title="BellettiA , BenedettoU , PutzuA , MartinoEA , Biondi‐ZoccaiG , AngeliniGD , et al. Vasopressors during cardiopulmonary resuscitation. A network meta‐analysis of randomized trials. Critical Care Medicine2018;46(5):e443‐51. ">Belletti 2018</a>), which was subsequently excluded based on non‐randomisation of the 'controls' and uncertainty about the random allocation of treatment arms of the study. Two ongoing studies (<a href="./references#CD003179-bbs2-0075" title="AndersenLW . Vasopressin and methylprednisolone for in‐hospital cardiac arrest (VAM‐IHCA). clinicaltrials.gov/ct2/show/NCT03640949 (first received 21 August 2018). ">Andersen 2018</a>; <a href="./references#CD003179-bbs2-0076" title="RaymondTT . A prospective, randomised, controlled trial of combination vasopressin and epinephrine to epinephrine only for in‐intensive care unit paediatric cardiopulmonary resuscitation. clinicaltrials.gov/ct2/show/NCT00628550 (first received 5 March 2008). ">Raymond 2008</a>) were also excluded, resulting in 80 papers for full‐text review. We excluded 48 papers at this stage, because they did not meet the study inclusion criteria after review of the text; see <a href="#CD003179-fig-0001">Figure 1</a>. We included 26 studies reported in 32 papers (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>), as shown in the <a href="./references#CD003179-sec-0122" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD003179-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Selection process" data-id="CD003179-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Selection process</p> </div> </div> </div> <p>The papers were published between 1992 and 2018, 13 of them before 2000 (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>), five from 2000 up to 2005 (<a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>), four from 2005 up to 2010 (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>), and four from 2010 onwards (<a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). A total of 21,704 participants were included in the analyses. Two Chinese papers (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) and one Japanese paper (<a href="./references#CD003179-bbs2-0054" title="NishizawaH , MiyazakiH , OgawaK , TakitaS , HashimotoK , SugiyamaM , etak . Comparison of standard‐dose epinephrine and high‐dose epinephrine in cardiopulmonary arrest outside the hospital. Kokyu to Junkan ‐ Respiration &amp; Circulation1993;41(11):1083‐7. ">Nishizawa 1993</a>) were translated into English. Three studies were specifically from paediatric populations (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>). </p> <p>There was substantial variation between studies in the number of participants included. In the three RCTs of adrenaline versus placebo the sample sizes varied from 194 (<a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>) to 534 (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>) and 8104 (<a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). Considering studies of high‐dose adrenaline versus standard‐dose adrenaline, the sample sizes ranged from 43 (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) to 3907 participants (<a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>), and for vasopressin versus standard‐dose adrenaline the sample sizes ranged from 30 (<a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>) to 1186 participants (<a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>). </p> </section> <section id="CD003179-sec-0063"> <h4 class="title">Included studies</h4> <p>Most of the studies (16/26) were of people who suffered OHCAs (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>), including one paediatric study (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>). In‐hospital cardiac arrests (IHCAs) included cardiac arrests in the Emergency Department (ED) and intensive care unit (ICU). Four studies (<a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>) included both out‐of‐hospital and in‐hospital cardiac arrest, one which was OHCA and ED (<a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>), and six in‐hospital (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>), two of which were paediatric studies (<a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>). </p> <p>Of the 26 studies included in this review, three studies compared adrenaline to placebo (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>). Fifteen studies compared standard‐dose adrenaline (SDA) with high‐dose adrenaline (HDA), ranging from 2 mg to 10 mg doses (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>); six studies compared SDA to vasopressin (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>); three studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) examined the effect of SDA and vasopressin combined with SDA. Note that <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a> is included in the SDA versus HDA analysis and the SDA versus vasopressin analysis. </p> <p>Five studies had more than one intervention group. <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a> reported results from the control group (SDA) compared to three intervention groups: HDA, standard‐dose vasopressin and high‐dose vasopressin. <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a> compared administration of SDA to 2 mg adrenaline every three minutes and also with increasing doses of adrenaline (1 mg adrenaline initially and then progressively increased dosage to 2 mg every three minutes). <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a> compared two different doses of adrenaline (5 mg and 10 mg) to SDA. Two studies compared SDA to HDA and noradrenaline (<a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>) or HDA administered with nitroglycerine (<a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>). We discarded the results from the noradrenaline arm and the HDA with nitroglycerine arm, because they did not meet the selection criteria. </p> <p>Most studies reported intravenous administration of the study drug. One study (<a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>) administered the study drug through the endobronchial route and three used a combination of routes: intravenous or by the endotracheal tube (<a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>); intravenous or intra‐osseous (<a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>); and intravenous, endobronchial or intra‐osseous (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>). </p> <section id="CD003179-sec-0064"> <h5 class="title">Baseline characteristics</h5> <p>Baseline characteristics were similar between groups for most of the studies, but the characteristics that were reported varied between studies. One study did not report baseline characteristics (<a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>). Differences in baseline characteristics between groups were evident in seven studies (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>). <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a> reported similar baseline characteristics in standard‐dose or placebo and high‐dose adrenaline groups, except for the time from Basic Life Support to Advanced Cardiac Life Support (P = 0.04), which was longer for the high‐dose adrenaline group. There were fewer men in the standard‐dose adrenaline group compared to the adrenaline plus vasopressin group in <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>, at 72% versus 75% (P = 0.03). <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a> found no difference in age, sex or the number of days in ICU, but the Acute Physiology Score 24 hours before the cardiac arrest and the dose of dobutamine administered were higher in the high‐dose adrenaline group. A higher proportion of participants with a medical history in the vasopressin group was reported by <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>, but the only significant history was higher hyperlipidaemia in the standard‐dose adrenaline group. <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a> reported that the prevalence of ischaemic heart disease was lower in the low‐dose adrenaline group. <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> reported a marginal difference in the proportion of participants whose cardiac arrest was witnessed by a bystander (53% placebo versus 44% adrenaline, P = 0.05). </p> <p>The mean age was 62 years for the control and intervention groups in the adult studies that reported age (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>). <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a> reported a median age of 67 years for both groups and <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> reported a mean age in both groups of 70 years. There were a similar proportion of adult men, around 66% in both groups. Two paediatric studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>) reported the mean age as 4.7 years in the control group and 4.5 years in the intervention group, and a similar proportion of boys in both group (56% versus 57%). </p> <p>The initial cardiac arrest rhythm was reported by all but four studies (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>); and was generally categorised as a shockable rhythm, i.e. ventricular fibrillation or (pulseless) ventricular tachycardia (VF/pVT) or a non‐shockable rhythm, i.e. asystole or pulseless electrical activity (PEA). PEA is characterised by "presence of spontaneous organized cardiac electric activity in the absence of blood flow sufficient to maintain consciousness" (<a href="./references#CD003179-bbs2-0104" title="Myerburg RJ HalperinH , EganDA , BoineauR , ChughSS , GillisAM , GoldhaberJI , LathropDA , LiuP , NiemannJT , OrnatoJP , SopkoG , VanEykJE , WalcottGP , WeisfeldtML , WrightJD , ZipesDP . Pulseless Electric Activity.. Circulation2013;128(23):2532‐41.. ">Myerburg 2013</a>). The proportion of participants with an initial rhythm of ventricular fibrillation (VF), asystole and pulseless electrical activity (PEA) were similar between control and intervention groups, but varied widely between studies (<a href="./appendices#CD003179-sec-0114">Appendix 2</a>). This included one study (<a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>) that only included people with ventricular fibrillation, two studies (<a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) that only included people with asystole and one study that only enrolled participants with asystole or PEA (<a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>). <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a> reported that 95% of the children overall had asystole. </p> <p>The proportion of arrests witnessed by a bystander was reported in 15 studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>), with bystander‐witnessed arrests ranging from 24% (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>) to close to 80% (<a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>). Witnessed EMS (paramedic‐witnessed) cardiac arrests were reported in three studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>), in 12% or fewer of participants. </p> <p>There were 14 studies that reported the proportion of participants that received bystander CPR (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>). Whilst the percentage of bystander CPR was similar in the intervention and control groups, there was considerable variation between studies, ranging from around 15% (<a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>) to almost 60% (<a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). </p> <p>The number of doses of study drug administered to a participant also varied between studies. A single dose of study drug was administered in four studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>), up to two doses in two studies (<a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>), three doses in three studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>), four doses in one study (<a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>), and five doses in three studies (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>, <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). The protocol for both of the standard‐dose adrenaline versus placebo controlled trials allowed up to 10 doses (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>), and up to 15 doses in two studies (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>). Studies were permitted to use open‐label adrenaline after the maximum doses of study drug. </p> </section> <section id="CD003179-sec-0065"> <h5 class="title">Outcomes</h5> <p>Several survival endpoints were used. Return of spontaneous circulation (ROSC) was the most common, although the actual definition was often not specified. Survival time to hospital discharge (STHD) was also often reported and survival to hospital admission (STHA) reported less often. Other endpoints included survival to one hour (<a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>), to 12 hours (<a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>), to 24 hours (<a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>), to three, eight, 15 and 21 days (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>), to 30 days (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> ), to six months (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>), to one year (<a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) and, in an ICU study, ICU survival (<a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>). Neuological outcomes were measured using various tools, as described under 'Neurological outcomes' below in <a href="#CD003179-sec-0079">Effects of interventions</a>. </p> <p>We used the 'N' randomised as the denominator for analyses as far as possible. However, we used the available 'n' where this was not clear, or where there was a large discrepancy between 'n' randomised and 'n' analysed, eg <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>. Similarly, we chose to use the amended denominator where loss to follow up for different outcomes (e.g. neurological ones) was described (eg <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>). There is therefore some discrepancy in the denominators across different outcomes within the same study. </p> <p>Different methods and time points were used to assess neurological outcome. Cerebral Performance Category (CPC) scores were used in 11 studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>), making it the most common measure of neurological outcome used. CPC was recorded most often at hospital discharge, but others recorded CPC at 96 hours (and at discharge) (<a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>) or at six months (<a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>). CPC scores were most often dichotomised into scores of less than three (i.e. 'good') and three to five (i.e. 'poor'). However, <a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a> dichotimised good outcomes as CPC one to three and poor outcomes as four and five according to whether the participant was conscious or unconscious, and <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a> reported the 'best category of cerebral performance', i.e. CPC = 1. <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> measured neurological outcomes at hospital discharge and at three months using the modified Rankin scale (<a href="./references#CD003179-bbs2-0115" title="QuinnTJ , DawsonJ , WaltersMR , LeesKR . Exploring the reliability of the modified rankin scale. Stroke2009;40(3):762‐6. ">Quinn 2009</a>). Survival with a favourable neurological outcome was defined as a score of three or less on the modified Rankin scale (which ranges from 0 (no symptoms) to 6 (death)). One study (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>) used the Glasgow Outcome Scale (<a href="./references#CD003179-bbs2-0091" title="JennettB , BondM . Assessment of outcome after severe brain damage. Lancet1975;1(7905):480‐4. ">Jennett 1975</a>), which has five categories: death, persistent vegetative state, severe disability, moderate disability, and good recovery. </p> <p>The Glasgow Coma Scale (GCS) (<a href="./references#CD003179-bbs2-0125" title="TeasdaleGM , PettigrewLE , WilsonJT , MurrayG , JennettB . Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. Journal of Neurotrauma1998;15(8):587‐97. ">Teasdale 1998</a>) was also used to assess neurological outcome (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>), albeit at different time points and using different summary measures. <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a> reported the highest GCS at hospital discharge; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a> reported the mean GCS at hospital discharge; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a> reported the highest GCS at the time of admission and at one week; and <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a> reported GCS at day 3 and day 21 after the OHCA. <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a> assessed GCS at different time points, but there were no survivors for assessment at hospital discharge. </p> <p>Two studies (<a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>) reported the median Mini‐Mental State Examination (MMSE) scores (<a href="./references#CD003179-bbs2-0126" title="TengEL , ChuiHC . The Modified Mini‐Mental State (3MS) examination. Journal of Clinical Psychiatry1987;48(8):314‐8. ">Teng 1987</a>) of OHCA survivors at hospital discharge. </p> <p>The two Chinese studies described neurological outcome as "discharged from hospital with 'normal' status" (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>). However, it is unclear whether only survivors with 'normal' status were included in the assessment of STHD. </p> <p>Hospital length of stay was only reported by two studies (<a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>) and neither study found a difference between the respective treatment groups. </p> </section> <section id="CD003179-sec-0066"> <h5 class="title">Funding</h5> <p>The source of funding was not stated in 11 of the 26 studies. The study drugs were provided or funded by the manufacturer in four out of 26 studies, but neither drug represents a profitable commercial option. The other 11 studies were funded by organisations such as research foundations and government funding bodies. </p> </section> </section> <section id="CD003179-sec-0067"> <h4 class="title">Excluded studies</h4> <p>Studies were excluded because they were non‐cardiac arrest papers (<a href="./references#CD003179-bbs2-0046" title="McCrirrickA , KestinI . Haemodynamic effects of tracheal compared with intravenous adrenaline. Lancet1992; Vol. 340, issue 8824:868‐70. ">McCrirrick 1992</a>; <a href="./references#CD003179-bbs2-0047" title="McCrirrickA , MonkCR . Comparison of i.v. and intra‐tracheal administration of adrenaline. British Journal of Anaesthesia1994; Vol. 72, issue 5:529‐32. ">McCrirrick 1994</a>, <a href="./references#CD003179-bbs2-0063" title="QuadrelM , LaveryRF , JakerM , AtkinS , TortellaBJ , CodyRP . Prospective, randomized trial of epinephrine, metaproterenol, and both in the prehospital treatment of asthma in the adult patient. Annals of Emergency Medicine1995; Vol. 26, issue 4:469‐73. ">Quadrel 1995</a>), reviews (<a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a>; <a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a>; <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a>; <a href="./references#CD003179-bbs2-0051" title="MeyerS , McGuireW , GottschlingS , Mohammed ShamdeenG , GortnerL . The role of vasopressin and terlipressin in catecholamine‐resistant shock and cardio‐circulatory arrest in children: review of the literature. Wiener Medizinische Wochenschrift2011;161:192‐203. ">Meyer 2011</a>; <a href="./references#CD003179-bbs2-0121" title="SillbergVA , PerryJJ , StiellIG , WellsGA . Is the combination of vasopressin and epinephrine superior to repeated doses of epinephrine alone in the treatment of cardiac arrest: a systematic review. Resuscitation2008;79(3):380‐6. ">Sillberg 2008</a>; <a href="./references#CD003179-bbs2-0134" title="XiaoliJ , DongpingW , HuiL , YanX , HongZ , XinL . Vasopressin and epinephrine versus epinephrine alone in management of patients with out of hospital cardiac arrest: a metaanalysis. Heart2010;96:A206‐A7. ">Xiaoli 2010</a>; <a href="./references#CD003179-bbs2-0074" title="ZwingmannJ , MehlhornAT , HammerT , BayerJ , SudkampNP , StrohmPC . Survival and neurologic outcome after traumatic out‐of‐hospital cardiopulmonary arrest in a pediatric and adult population: a systematic review. Critical Care2012;16(4):R117. ">Zwingmann 2012</a>), narratives (<a href="./references#CD003179-bbs2-0062" title="PellegrinoAM . Does vasopressin improve survival?. Emergency Medical Services2006;35(3):86‐92. ">Pellegrino 2006</a>; <a href="./references#CD003179-bbs2-0028" title="BerthierJC . Adrenaline: a new beginning. Pediatrie1987;42:7‐12. ">Berthier 1987</a>; <a href="./references#CD003179-bbs2-0035" title="CohenMR , TurcoSJ . Parenteral drugs used in cardiopulmonary resuscitation. Bulletin of the Parenteral Drug Association1975;29(1):39‐45. ">Cohen 1975</a>), editorials (<a href="./references#CD003179-bbs2-0048" title="McIntyreKM . Vasopressin in asystolic cardiac arrest. New England Journal of Medicine2004; Vol. 350, issue 2:179‐81. [0028‐4793] ">McIntyre 2004</a>) or critiques (<a href="./references#CD003179-bbs2-0072" title="WorsterA , UpadhyeS , FernandesCM . Vasopressin versus epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Canadian Journal of Emergency Medicine2005;7(1):48‐50. [1481‐8035] ">Worster 2005</a>), before‐and‐after studies (<a href="./references#CD003179-bbs2-0034" title="CarvolthRD , HamiltonAJ . Comparison of high‐dose epinephrine versus standard‐dose epinephrine in adult cardiac arrest in the prehospital setting. Prehospital and Disaster Medicine1996; Vol. 11, issue 3:219‐22. ">Carvolth 1996</a>), cohort studies (<a href="./references#CD003179-bbs2-0037" title="DieckmannRA , VardisR . High‐dose epinephrine in pediatric out‐of‐hospital cardiopulmonary arrest. Pediatrics1995; Vol. 95, issue 6:901‐13. ">Dieckmann 1995</a>), other non‐RCTs (<a href="./references#CD003179-bbs2-0052" title="MorrisDC , DereczykBE , GrzybowskiM , MartinGB , RiversEP , WortsmanJ , et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Academic Emergency Medicine1997; Vol. 4, issue 9:878‐83. ">Morris 1997</a>; <a href="./references#CD003179-bbs2-0053" title='NiemannJT , StrattonSJ . Endotracheal versus intravenous epinephrine and atropine in out‐of‐hospital "primary" and postcountershock asystole. Critical Care Medicine2000; Vol. 28, issue 6:1815‐9. '>Niemann 2000</a>; <a href="./references#CD003179-bbs2-0055" title="OhshigeK , ShimazakiS , HirasawaH , NakamuraM , KinH , FujiiC , et al. Evaluation of out‐of‐hospital cardiopulmonary resuscitation with resuscitative drugs: A prospective comparative study in Japan. Resuscitation2005, issue 1:53‐61. ">Ohshige 2005</a>) or used surrogate measures not included in our systematic review's selection criteria (<a href="./references#CD003179-bbs2-0060" title="ParadisNA , MartinGB , RosenbergJ , RiversEP , GoettingMG , AppletonTJ , et al. The effect of standard‐ and high‐dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA1991; Vol. 265, issue 9:1139‐44. ">Paradis 1991</a>; <a href="./references#CD003179-bbs2-0065" title="QuintonDN , O'ByrneG , AitkenheadAR . Comparison of endotracheal and peripheral intravenous adrenaline in cardiac arrest. Is the endotracheal route reliable?. Lancet1987; Vol. 1, issue 8537:828‐9. ">Quinton 1987</a>; <a href="./references#CD003179-bbs2-0071" title="WoodhouseSP , Lewis‐DriverD , EllerH . Catecholamines during cardiopulmonary resuscitation for cardiac arrest. Resuscitation1992; Vol. 24, issue 3:263‐72. ">Woodhouse 1992</a>). Eight RCTs were excluded because they were of drugs not included in this systematic review's selection criteria (<a href="./references#CD003179-bbs2-0049" title="MentzelopoulosS , KatsiosN , PapastylianouA , GisiotiS , StathopoulosA , StamatakiE , et al. Vasopressin, epinephrine, and methylprednisolone in inhospital cardiac arrest. Critical Care. London, 2007; Vol. 11, issue Suppl 2:324. ">Mentzelopoulos 2007</a>; <a href="./references#CD003179-bbs2-0050" title="MentzelopoulosSD , ZakynthinosSG , TzoufiM , KatsiosN , PapastylianouA , GkisiotiS , et al. Vasopressin, epinephrine, and corticosteroids for in‐hospital cardiac arrest. Archives of Internal Medicine2009;169(1):15‐24. ">Mentzelopoulos 2009</a>; <a href="./references#CD003179-bbs2-0056" title="OlasveengenTM , SundeK , BrunborgC , ThowsenJ , SteenPA , WikL . Intravenous drug administration during out‐of‐hospital cardiac arrest: a randomized trial. JAMA2010;302:2222‐9. ">Olasveengen 2009</a>; <a href="./references#CD003179-bbs2-0058" title="OlsonDW , ThakurR , StuevenHA , ThompsonB , GruchowH , HendleyGE , et al. Randomized study of epinephrine versus methoxamine in prehospital ventricular fibrillation. Annals of Emergency Medicine1989; Vol. 18, issue 3:250‐3. ">Olson 1989</a>; <a href="./references#CD003179-bbs2-0061" title="PatrickWD , FreedmanJ , McEwenT , LightRB , LudwigL , RobertsD . A randomized, double‐blind comparison of methoxamine and epinephrine in human cardiopulmonary arrest. American Journal of Respiratory and Critical Care Medicine1995; Vol. 152, issue 2:519‐23. ">Patrick 1995</a>; <a href="./references#CD003179-bbs2-0068" title="SongDF . Comparison between epinephrine and methoxamine for emergency treatment of the patients with sudden heart arrest. Chinese Journal of Anesthesiology1997; Vol. 17, issue 2:108. ">Song 1997</a>; <a href="./references#CD003179-bbs2-0069" title="TurnerLM , ParsonsM , LuetkemeyerRC , RuthmanJC , AndersonRJ , AldagJC . A comparison of epinephrine and methoxamine for resuscitation from electromechanical dissociation in human beings. Annals of Emergency Medicine1988; Vol. 17, issue 5:443‐9. ">Turner 1988</a>; <a href="./references#CD003179-bbs2-0070" title="WeaverWD , FahrenbruchCE , JohnsonDD , HallstromAP , CobbLA , CopassMK . Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation1990; Vol. 82, issue 6:2027‐34. ">Weaver 1990</a>). For example, Mentzelopoulos (<a href="./references#CD003179-bbs2-0049" title="MentzelopoulosS , KatsiosN , PapastylianouA , GisiotiS , StathopoulosA , StamatakiE , et al. Vasopressin, epinephrine, and methylprednisolone in inhospital cardiac arrest. Critical Care. London, 2007; Vol. 11, issue Suppl 2:324. ">Mentzelopoulos 2007</a>; <a href="./references#CD003179-bbs2-0050" title="MentzelopoulosSD , ZakynthinosSG , TzoufiM , KatsiosN , PapastylianouA , GkisiotiS , et al. Vasopressin, epinephrine, and corticosteroids for in‐hospital cardiac arrest. Archives of Internal Medicine2009;169(1):15‐24. ">Mentzelopoulos 2009</a>) included methylprednisolone with vasopressin and adrenaline to compare the effect on outcomes with standard‐dose adrenaline. The study found increased ROSC and STHD in the combination group, but it is unclear whether the results were related to methylprednisolone or a combination of the drugs used (<a href="./references#CD003179-bbs2-0050" title="MentzelopoulosSD , ZakynthinosSG , TzoufiM , KatsiosN , PapastylianouA , GkisiotiS , et al. Vasopressin, epinephrine, and corticosteroids for in‐hospital cardiac arrest. Archives of Internal Medicine2009;169(1):15‐24. ">Mentzelopoulos 2009</a>). We excluded <a href="./references#CD003179-bbs2-0056" title="OlasveengenTM , SundeK , BrunborgC , ThowsenJ , SteenPA , WikL . Intravenous drug administration during out‐of‐hospital cardiac arrest: a randomized trial. JAMA2010;302:2222‐9. ">Olasveengen 2009</a> because the study included all intravenous drugs and was not limited to the drugs included in our systematic review, i.e. adrenaline, vasopressin (or terlipressin). <a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a> was excluded because it was a pilot study of 10 participants from a larger RCT in progress, of which few details were provided in the conference report, no record of the study could be found, and we were unsuccessful in contacting the authors. <a href="./references#CD003179-bbs2-0039" title="GhafourianN , ManiaeNH , TaherikalaniM , MehraziM , HossieniM , ValianF , et al. Combination of vasopressin ‐ epinephrine as a novel candidate in patients with cardiac arrest. Recent Advances in Cardiovascular Drug Discovery2015;10(1):65‐9. ">Ghafourian 2015</a>), identified from a recent systematic review (<a href="./references#CD003179-bbs2-0079" title="BellettiA , BenedettoU , PutzuA , MartinoEA , Biondi‐ZoccaiG , AngeliniGD , et al. Vasopressors during cardiopulmonary resuscitation. A network meta‐analysis of randomized trials. Critical Care Medicine2018;46(5):e443‐51. ">Belletti 2018</a>), was excluded based on non‐randomisation of the 'controls' and uncertainty about the random allocation of treatment arms of the study. The two ongoing studies (<a href="./references#CD003179-bbs2-0075" title="AndersenLW . Vasopressin and methylprednisolone for in‐hospital cardiac arrest (VAM‐IHCA). clinicaltrials.gov/ct2/show/NCT03640949 (first received 21 August 2018). ">Andersen 2018</a>; <a href="./references#CD003179-bbs2-0076" title="RaymondTT . A prospective, randomised, controlled trial of combination vasopressin and epinephrine to epinephrine only for in‐intensive care unit paediatric cardiopulmonary resuscitation. clinicaltrials.gov/ct2/show/NCT00628550 (first received 5 March 2008). ">Raymond 2008</a>), the details of which can be found in <a href="./references#CD003179-sec-0124" title="">Characteristics of ongoing studies</a>, are not included in the analysis because of lack of data. </p> </section> </section> <section id="CD003179-sec-0068"> <h3 class="title">Risk of bias in included studies</h3> <p>The results of our assessment of risks of bias in the included studies can be seen in the <a href="#CD003179-sec-0061">Description of studies</a> table and are summarised in <a href="#CD003179-fig-0002">Figure 2</a> and <a href="#CD003179-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD003179-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003179-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD003179-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003179-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD003179-sec-0069"> <h4 class="title">Allocation</h4> <section id="CD003179-sec-0070"> <h5 class="title">Random sequence generation</h5> <p>All studies were randomised with the exception of one quasi‐randomised trial (<a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>). Eleven studies reported a computer‐generated randomisation sequence (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>). Three studies used a central randomisation schedule (<a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>). We rated these 14 studies at low risk of bias. Ten studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) stated that the study was “randomised” but did not report the method used for randomisation. We rated these 10 studies as unclear riskWe judged two studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>) to be at high risk for bias. In a paediatric study of OHCA, <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a> used computer‐generated randomisation for six centres, while the other centre assigned participants to the study group if their medical record number ended in an odd number and to the standard‐dose group if their medical record number ended in an even number. Quasi‐randomisation using alternation, in which the study drug and dose were changed for the entire city on Wednesdays, was used by <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>. </p> </section> <section id="CD003179-sec-0071"> <h5 class="title"> Allocation concealment</h5> <p>Nineteen studies described allocation concealment (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>) and were considered as low risk. In <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a> it was uncertain whether the opaque envelopes were tamper‐proof, and we rated the study as being at unclear risk of bias. Paramedics could have altered the dose given in <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>, and we considered the study to be at high risk; as we did so for <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; and <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>. Three studies did not report any information about allocation concealment (<a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) and were rated at unclear risk of bias. </p> </section> </section> <section id="CD003179-sec-0072"> <h4 class="title">Blinding</h4> <section id="CD003179-sec-0073"> <h5 class="title"> Blinding (performance bias and detection bias): survival outcomes</h5> <p>Blinding was described in 18 studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>). We rated three studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) at high risk of bias. Blinding was only used in two of the seven centres because of technical difficulty in <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>. The other two studies (<a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998)</a> were unblinded to the drug dose administered. Blinding was unknown in five studies (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) and we rated them at unclear risk of bias. </p> </section> <section id="CD003179-sec-0074"> <h5 class="title"> Blinding (performance bias and detection bias): neurological outcome</h5> <p>Four studies were blinded to group allocation for neurological outcome (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>) and we rated them at low risk, but for most studies it was unclear whether the assessor was aware of the allocation group (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) and we rated them at unclear risk of bias. Blinding was not reported in <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>, but the Glasgow Coma Score (GCS) and electroencephalogram (EEG) are susceptible to bias because of the small sample size, with neurological assessments not being performed systematically, but were "made by different physicians" and "particular therapies given in the different hospitals could not be controlled". <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a> did not blind caregivers to the drug dose administered which we rated at a high risk of bias. No neurological outcomes were reported in nine studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>). </p> </section> </section> <section id="CD003179-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>Most studies accounted for all their outcome data and we rated them at low risk (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>;; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>). </p> <p>Many studies (<a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) claimed to perform intention‐to‐treat analysis, i.e. including all randomised cases in the analysis, but some were 'per protocol' analyses because they did not include those participants who were randomised but later excluded, e.g. because of not meeting selection criteria, missing data, or unclear group allocation. </p> <p>We assessed five studies as high risk of attrition bias. <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> planned to enrol 5000 participants. Enrolment issues, withdrawal of participating centres, and lack of willingness of paramedics to participate in a trial involving a placebo were responsible for enrolment being restricted to 601 participants (12% of the original sample size), of whom 534 had their data analysed. We therefore assessed this study at high risk for incomplete outcome reporting. <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a> excluded 37% of cases after randomisation and <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a> excluded 35% because of "irregularities in dosing or incomplete documentation". <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a> excluded 10 participants for protocol violations, 7 for inadequate records and 145 participants received open‐label 1mg adrenaline instead of study drug. <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a> exclude 580 participants (15% of the total) from the final analysis, for various reasons. </p> <p><a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a> had more than 10% of the randomised cohort excluded from the study but was rated at low risk. <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a> had 20% of participants who survived to hospital discharge but were lost to follow‐up for neurological outcome. Three studies were rated as unclear risk of attrition bias (<a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>) </p> </section> <section id="CD003179-sec-0076"> <h4 class="title">Selective reporting</h4> <p>We reviewed the published papers for details of the outcomes that were assessed. All but four studies were assessed as unclear for this domain. <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a> listed STHD as an outcome measure but it was not reported, so this study was assessed as being at high risk of bias. <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a> was assessed as being at high risk of reporting bias because only ROSC was reported for VF and Asystole patients. <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> and <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> were assessed as being at low risk of selective reporting. </p> </section> <section id="CD003179-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>All but four studies (<a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>) were assessed unclear risk of other bias. No study compared post‐resuscitation care in the study groups. We considered <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a> to be at high risk of other bias due to presenting baseline characteristics and some outcomes for the intervention group only. <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a> was only available as a conference abstract so was also considered to be at high risk of 'other' bias. We rated <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a> at high risk of bias in the 'Other bias' section: enrolment was discontinued before reaching the recruitment target because of “geographic relocation of investigators, concerns re deferred consent, intercurrent results of recent trials, similar trials”. In addition, intention‐to‐treat was not stated and participants who received the study drug but did not meet the entrance requirement were excluded from data analysis.We also rated the <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a> study as being at high risk of other bias as the supervising physician was stated to treat patients differently depending on their allocated group. </p> <p><a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a> and <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a> provided insufficient detail in several categories in the 'Risk of bias' assessment, and we rated them at high risk of potential bias overall. </p> <section id="CD003179-sec-0078"> <h5 class="title">Publication bias</h5> <p>Funnel plots for high‐dose adrenaline versus standard‐dose adrenaline are shown in <a href="#CD003179-fig-0004">Figure 4</a> for ROSC and <a href="#CD003179-fig-0005">Figure 5</a> for STHD. We did not produce funnel plots for other outcomes or comparisons, due to limited studies (fewer then 10). Visual analysis of the funnel plots revealed that they were roughly not symmetrical, suggesting the possibility of publication bias. The funnel plot for ROSC (<a href="#CD003179-fig-0004">Figure 4</a>) suggests a lack of small studies with an RR of less than about 1.1 (the point estimate for the biggest studies), which could be due to publication bias. The funnel plot for survival (<a href="#CD003179-fig-0005">Figure 5</a>) looks less asymmetrical, but there is still only one small study on the left side of the plot versus several on the right. </p> <div class="figure" id="CD003179-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.8 ROSC (adults vs children)." data-id="CD003179-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.8 ROSC (adults vs children). </p> </div> </div> </div> <div class="figure" id="CD003179-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.1 Survival to hospital discharge." data-id="CD003179-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.1 Survival to hospital discharge. </p> </div> </div> </div> </section> </section> </section> <section id="CD003179-sec-0079"> <h3 class="title" id="CD003179-sec-0079">Effects of interventions</h3> <p>See: <a href="./full#CD003179-tbl-0001"><b>Summary of findings for the main comparison</b> Standard‐dose adrenaline (SDA) compared to placebo for cardiac arrest</a>; <a href="./full#CD003179-tbl-0002"><b>Summary of findings 2</b> Standard‐dose adrenaline (SDA) compared to high‐dose adrenaline (HDA) for cardiac arrest</a>; <a href="./full#CD003179-tbl-0003"><b>Summary of findings 3</b> Standard‐dose adrenaline (SDA) compared to vasopressin for cardiac arrest</a>; <a href="./full#CD003179-tbl-0004"><b>Summary of findings 4</b> Standard‐dose adrenaline (SDA) compared to SDA plus vasopressin for cardiac arrest</a> </p> <section id="CD003179-sec-0080"> <h4 class="title">Survival to hospital discharge (STHD)</h4> <section id="CD003179-sec-0081"> <h5 class="title">STHD: Adrenaline versus placebo</h5> <p>Two studies compared standard‐dose adrenaline (multiple doses) versus placebo (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>), and one smaller study (<a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>) compared high‐dose adrenaline (2 x 10 mg doses) versus placebo before reverting back to standard (1 mg) doses of adrenaline. In the <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a> study there were no survivors to hospital discharge in either the high‐dose adrenaline or placebo groups, and hence the pooled RR for adrenaline versus placebo is calculated from the two studies with events (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> (standard‐dose adrenaline versus placebo) reported limited evidence of a difference in STHD, with the effect estimate suggesting a possible two‐fold increase but the confidence interval indicating great uncertainty that could include either a small decrease or a very large increase (risk ratio (RR) 2.12, 95% confidence interval (CI) 0.75 to 6.02; 534 participants). The larger <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> study reported an increase in STHD for participants in the intervention (adrenaline) group compared to the placebo group (RR 1.40, 95% CI 1.08 to 1.83; 8004 participants). The pooled estimate for standard‐dose adrenaline versus placebo showed an increase in STHD in favour of adrenaline: RR 1.44, 95% CI 1.11 to 1.86; 2 studies; 8538 participants; I<sup>2</sup> = 0%; moderate‐quality evidence; <a href="./references#CD003179-fig-0006" title="">Analysis 1.1</a>. </p> </section> <section id="CD003179-sec-0082"> <h5 class="title">STHD: Standard‐dose adrenaline (SDA) versus high‐dose adrenaline (HDA)</h5> <p>Nine adult studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) and three paediatric studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) reported STHD for the comparison of high‐dose adrenaline (HDA) versus standard‐dose adrenaline (SDA). There was considerable variation between studies in unadjusted STHD, ranging from 0% to 14% in the HDA group and 0% to 5% in the SDA group for adults; 0% to 20% in the HDA group to 0% to 12% in the SDA group for paediatric studies. Two of the studies comparing SDA versus HDA and reporting STHD had zero events in both arms of the study (<a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>), meaning that we did not include these two studies in our calculation of the pooled RR for <a href="./references#CD003179-fig-0010" title="">Analysis 2.1,</a> nor in the subgroup analyses in <a href="./references#CD003179-fig-0011" title="">Analysis 2.2</a> and <a href="./references#CD003179-fig-0012" title="">Analysis 2.3</a>. There was no evidence of a statistically significant difference in the pooled estimate for STHD in HDA versus SDA: RR 1.10, 95% CI 0.75 to 1.62; participants = 6274; studies = 10; I<sup>2</sup> = 24%; very low‐quality evidence; <a href="./references#CD003179-fig-0010" title="">Analysis 2.1</a>. <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a> did not report STHD, but did report 21‐day survival. Including <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a> in the pooled analysis (i.e. equating 21‐day survival with STHD) only slightly affected the effect estimate and the 95% confidence intervals, but not the conclusion of no effect.(RR 1.17, 95% CI 0.80 to 1.71; participants = 6810; studies = 11; I<sup>2</sup> = 25%) The very low‐quality of the evidence for these two analyses means that we are uncertain of the effect of SDA compared with HDA on survival to hospital discharge. </p> <p>We conducted two predefined subgroup analyses: (1) adults and children; and (2) IHCA and OHCA events.<br/> <br/> (1) Three paediatric studies, one of OHCA (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>), and two of IHCA (<a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) compared high‐dose to standard‐dose adrenaline. Whilst there was no evidence of a statistically significant difference in STHD (RR 1.54, 95% CI 0.17, 13.66 ; 3 studies; 317 participants), there was high clinical and statistical heterogeneity (I<sup>2</sup> = 61%; <a href="./references#CD003179-fig-0011" title="">Analysis 2.2</a>). There was no evidence of subgroup difference in STHD for adults versus children: Test for subgroup differences: Chi<sup>2</sup> = 0.17, df = 1 (P = 0.68), I<sup>2</sup> = 0.0%.<br/> <br/> (2) Six of the studies were OHCA (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a> (not included in the meta‐analysis) ; and <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a> (not included in the meta‐analysis); four were IHCA (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>). Two studies (<a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>) included both IHCA and OHCA (adult) participants. The <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a> was excluded from the IHCA/OHCA subgroup analysis, as it was not possible to distinguish results for the IHCA/OHCA groups. There was no evidence of subgroup difference in STHD for SDA compared to HDA in OHCA studies versus IHCA studies: Test for subgroup differences: Chi<sup>2</sup> = 0.30, df = 1 (P = 0.58), I<sup>2</sup> = 0%; <a href="./references#CD003179-fig-0012" title="">Analysis 2.3</a>. </p> </section> <section id="CD003179-sec-0083"> <h5 class="title">STHD: Standard‐dose adrenaline versus vasopressin</h5> <p>The pooled estimate for the six studies (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) that compared SDA to vasopressin showed no evidence of a statistically significant difference in STHD among 2511 participants: RR 1.25, 95% CI 0.84 to 1.85; I<sup>2</sup> = 29%; very low‐quality evidence; <a href="./references#CD003179-fig-0018" title="">Analysis 3.1</a>. The very low quality of evidence means that we are uncertain of the effect of SDA versus vasopressin on STHD. Considering STHD for the three OHCA studies only (<a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>), there was no evidence of a statistically significant difference in the pooled results: RR 1.26, 95% CI 0.76 to 2.07; 1542 participants, I<sup>2</sup> = 29%,; <a href="./references#CD003179-fig-0019" title="">Analysis 3.2</a>). Similarly, there was no evidence of a statistically significant difference in STHD between SDA versus vasopressin for IHCA participants (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>): RR 2.21, 95% CI 0.29 to 17.06; 242 participants, but heterogeneity was very high (I<sup>2</sup> = 77%; P = 0.04). There was no evidence of OHCA/IHCA subgroup difference in STHD: Test for subgroup differences: Chi<sup>2</sup> = 0.28, df = 1 (P = 0.60), I<sup>2</sup> = 0%; <a href="./references#CD003179-fig-0019" title="">Analysis 3.2</a>. </p> </section> <section id="CD003179-sec-0084"> <h5 class="title">STHD: Standard‐dose adrenaline versus vasopressin plus adrenaline</h5> <p>Three studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) compared SDA to SDA plus vasopressin. <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a> found no evidence of a statistically significant difference between the SDA‐plus‐vasopressin group compared to the SDA (and placebo) group for STHD after OHCA: RR 0.73, 95% CI 0.43 to 1.23; 2887 participants. <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a> compared vasopressin to placebo after both groups had received a dose of SDA and reported 30‐day survival, not STHD. There was no evidence of a statistically significant difference in 30‐day survival between the groups: RR 1.18, 95% CI 0.32 to 4.32; 325 participants. In a small study (N = 30), <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a> compared up to three successive doses of SDA versus SDA plus vasopressin and found no evidence of a statistically significant difference in STHD: RR 0.23, 95% CI 0.01 to 4.36. In a pooled analysis there was no evidence of a statistically significant difference in STHD/30‐day survival, but the very low quality of the evidence means that we are uncertain of the effect on this outcome: RR 0.76, 95% CI 0.47 to 1.22; 3 studies; 3242 participants; I<sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#CD003179-fig-0024" title="">Analysis 4.1</a>. </p> </section> </section> <section id="CD003179-sec-0085"> <h4 class="title">Survival to hospital admission (STHA)</h4> <section id="CD003179-sec-0086"> <h5 class="title">STHA: Adrenaline versus placebo</h5> <p>Both <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> and <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> found a two to three‐fold increase in STHA for adult participants who received SDA compared to placebo. The pooled estimate of the two studies showed an increase in STHA for participants in the intervention (adrenaline) group compared to placebo group: RR 2.51, 95% CI 1.67 to 3.76; 8489 participants; I<sup>2</sup> = 77%; moderate‐quality evidence; <a href="./references#CD003179-fig-0007" title="">Analysis 1.2</a>. <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a> did not report STHA. </p> </section> <section id="CD003179-sec-0087"> <h5 class="title">STHA: Standard‐dose adrenaline (SDA) versus high‐dose adrenaline (HDA)</h5> <p>Five studies in adults (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>) reported the proportion of people surviving to hospital admission among those who received HDA compared to SDA. The pooled estimate showed a 13% increase in STHA for the HDA group: RR 1.13, 95% CI 1.03 to 1.24; 5 studies; 5764 participants; I<sup>2</sup> = 0%; <a href="./references#CD003179-fig-0013" title="">Analysis 2.4</a>. However, the very low quality of evidence suggests uncertainty in the effect for this outcome. No paediatric study reported STHA. </p> <p>Survival to 24 hours was reported by five studies (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>) that compared HDA to SDA. In the individual studies, there was no evidence of a difference in 24‐hour survival between HDA and SDA in the three adult studies (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>), nor the two paediatric studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>). . The pooled estimate found no evidence of a statistically significant difference in 24‐hour survival between HDA and SDA: (RR 1.04, 95% CI 0.76 to 1.43; participants = 4179; studies = 5; I<sup>2</sup> = 39%); <a href="./references#CD003179-fig-0014" title="">Analysis 2.5</a>. </p> </section> <section id="CD003179-sec-0088"> <h5 class="title">STHA: Standard‐dose adrenaline versus vasopressin</h5> <p>Administration of vasopressin was associated with increased STHA compared to SDA when we combined the results from the three studies (<a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) reporting this endpoint: RR 1.27, 95% CI 1.04 to 1.54; 3 studies; 1953 participants; I<sup>2</sup> = 27%; low‐quality evidence; <a href="./references#CD003179-fig-0020" title="">Analysis 3.3</a>. </p> </section> <section id="CD003179-sec-0089"> <h5 class="title">STHA: Standard‐dose adrenaline versus vasopressin plus adrenaline</h5> <p>A pooled estimate of the effect of vasopressin and adrenaline compared to SDA from three studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) showed no effect on STHA: RR 0.95, 95% CI 0.83 to 1.08; 3 studies; 3249 participants; I<sup>2</sup> = 0%; low‐quality evidence; <a href="./references#CD003179-fig-0025" title="">Analysis 4.2</a>. </p> </section> </section> <section id="CD003179-sec-0090"> <h4 class="title">Neurological outcome</h4> <section id="CD003179-sec-0091"> <h5 class="title">Neurological outcome: Adrenaline versus placebo</h5> <p>In the <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> study, nine of the 11 survivors (3.1% overall) in the SDA group had a favourable neurological outcome (CPC &lt; 3) at hospital discharge, whilst all five of the surviving participants in the placebo group (1.9% overall) had a favourable neurological outcome: RR 1.73, 95% CI 0.59 to 5.11; 534 participants. In the <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> study, there was no difference in the percentage of participants who had a favourable neurological outcome at hospital discharge (mRs ≤ 3) (or at three months after the OHCA) between the SDA (2.2%) and placebo (1.9%) groups: RR 1.17, 95% CI 0.86 to 1.59; 8001 participants. The pooled estimate of SDA versus placebo showed no statistically significant difference in favourable neurological outcome between the SDA and placebo groups: RR 1.21, 95% CI 0.90 to 1.62; 2 studies; 8535 participants; I<sup>2</sup> = 0%; low‐quality evidence; <a href="./references#CD003179-fig-0008" title="">Analysis 1.3</a>. However, <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> also showed that severe neurologic impairment at hospital discharge (a mRs of 4 or 5) was more frequent in the SDA group than in the placebo group (39 of 126 participants (31.0%) versus 16 of 90 participants (17.8%)). </p> </section> <section id="CD003179-sec-0092"> <h5 class="title">Neurological outcome: Standard‐dose adrenaline versus high‐dose adrenaline</h5> <p>Two studies (<a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>) reported CPC scores &lt; 3 for participants receiving SDA or HDA, with neither finding evidence of a difference in neurological outcome between the SDA and HDA groups. <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a> reported CPC scores category '1' and found no evidence of difference between the SDA and HDA groups (RR 0.63, 95% CI 0.28 to 1.42; 650 participants). <a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a> recorded CPC score categories &lt; 4, i.e. "conscious at time of hospital discharge" and reported 92% of participants in the SDA group who survived to hospital discharge and 94% in the HDA group had CPC &lt; 4. Including this study with the others reporting CPC scores (i.e. <a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>), there was no evidence of a statistically significant difference in the effect of SDA versus HDA on 'good' neurological outcomes: (RR 0.91, 95% CI 0.65 to 1.26; participants = 5803; studies = 4; I<sup>2</sup> = 0%); <a href="./references#CD003179-fig-0015" title="">Analysis 2.6</a>. The very low quality of evidence means that we are uncertain of the effect of SDA versus HDA on this outcome. Neurological outcome in the <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a> study was described as "discharged from hospital with pre‐arrest conscious state, heart rate and respiratory rate status" ‐ and was not included in the meta‐analysis. The GCS neurological assessments in <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a> at day 3 and day 21 were made by different physicians and (according to the authors) "were not systematically performed"; so we have not included these results in the meta‐analysis. However, the authors reported that there was no evidence of difference in GCS between the intervention SDA and HDA groups (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>). </p> <p>Three paediatric studies comparing SDA to HDA assessed neurological outcome (<a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>). Given the small number of survivors in each study and the different assessment tools used, we provide a narrative summary. <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a> reported no survivors in the HDA group; in the SDA group, two children had a paediatric CPC score of '1' and the other two children (who were impaired before the hospital cardiac arrest) had the same neurological outcome after the IHCA. <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a> used an adapted Glasgow Outcome Scale (<a href="./references#CD003179-bbs2-0091" title="JennettB , BondM . Assessment of outcome after severe brain damage. Lancet1975;1(7905):480‐4. ">Jennett 1975</a>) to assess neurological outcome at hospital discharge. In the HDA group two children had good, one had moderate and six children had a severe neurological outcome. Both surviving children in the SDA group had severe neurological outcome (P = 0.51). <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a> reported no survivors in the SDA group, and of the two survivors in the HDA group both had "neurologic damage" at hospital discharge. </p> </section> <section id="CD003179-sec-0093"> <h5 class="title">Neurological outcome: Standard‐dose adrenaline versus vasopressin</h5> <p>For the four studies (<a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) that reported neurological outcome as CPCs for the vasopressin versus SDA comparison, there was no evidence of a statistically significant difference in the pooled result: RR 0.82, 95% CI 0.54 to 1.25; participants = 2406; studies = 4; I<sup>2</sup> = 0%; <a href="./references#CD003179-fig-0021" title="">Analysis 3.4</a>. The very low quality of the evidence indicates uncertainty around this outcome. <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a> followed up participants to one year and reported no evidence for a difference between the SDA and vasopressin groups at that time. <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a> reported no evidence of a difference in the mean(sd) Glasgow Coma Scale scores for the three STHD participants in the SDA group compared to the eight STHD participants in the vasopressin group (10.7 (3.8) versus 11.7 (1.6), P = 0.78), but this was not included in the meta‐analysis due to the use of a different neurologic assessment scale. </p> </section> <section id="CD003179-sec-0094"> <h5 class="title">Neurological outcome: Standard‐dose adrenaline versus vasopressin plus adrenaline</h5> <p><a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a> compared CPC scores &lt; 3 between the SDA plus vasopressin group and the SDA with placebo group, and found no evidence of difference in CPC scores: RR 0.65, 95% CI 0.33 to 1.31; participants = 887; studies = 1; very low‐quality evidence; <a href="./references#CD003179-fig-0026" title="">Analysis 4.3</a>. </p> </section> </section> <section id="CD003179-sec-0095"> <h4 class="title">Return of spontaneous circulation (ROSC)</h4> <section id="CD003179-sec-0096"> <h5 class="title">ROSC: Adrenaline versus placebo</h5> <p><a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a> reported that pre‐hospital ROSC in OHCA was significantly higher in the SDA group when compared to placebo: RR 2.80, 95% CI 1.78 to 4.41; participants = 534. Similarly, <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> reported more than a tripling of the proportion of participants achieving pre‐hospital ROSC in the SDA group (36.3% versus 11.7%; RR 3.10, 95% CI 2.82 to 3.41; participants = 7935). In the <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a> study, immediate survival, defined as “stable cardiac rhythm with palpable pulse at time cardiac arrest team left”, was higher, but not significantly different in OHCA in the HDA group compared to placebo (RR 1.37, 95% CI 0.53 to 3.53; participants = 194). </p> <p>The pooled estimate for the three studies (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>) that compared the effect of adrenaline versus placebo on the proportion of participants who achieved ROSC was: RR 2.86, 95% CI 2.21 to 3.71; participants = 8663; studies = 3; I<sup>2</sup> = 33% ; <a href="./references#CD003179-fig-0009" title="">Analysis 1.4</a>. Removal of the <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a> study, which had a high risk of bias (see <a href="#CD003179-fig-0002">Figure 2</a>) and a different experimental intervention (HDA compared to placebo), had minimal effect on the pooled estimate (RR 3.09, 95% CI 2.82 to 3.39; participants = 8469; studies = 3; I<sup>2</sup> = 0%). </p> </section> <section id="CD003179-sec-0097"> <h5 class="title">ROSC: Standard‐dose adrenaline versus high‐dose adrenaline</h5> <p>Of the 7014 participants (adults and children) in the 13 studies (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>;) that compared ROSC in participants receiving HDA or SDA, there was a small increase in ROSC of 15% in the HDA group: RR 1.15, 95% CI 1.02 to 1.29; I<sup>2</sup> = 34%; <a href="./references#CD003179-fig-0017" title="">Analysis 2.8</a>. The very low quality of evidence means there is uncertainty around this outcome. There was no substantial change in the estimate with the removal of <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a> (excluded because of a high risk of bias). </p> <p>Two studies also compared graded doses of adrenaline (<a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) or 5 mg adrenaline (<a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>) to SDA and found similar results to participants receiving HDA, as shown in the <a href="./references#CD003179-sec-0122" title="">Characteristics of included studies</a> table. The pooled estimate for the four studies (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) that were conducted in‐hospital showed a slight increase in the relative risk of ROSC but the confidence interval also includes the possibility of no effect or even a small decrease: RR 1.78, 95% CI 0.82 to 3.88; participants = 190; <a href="./references#CD003179-fig-0016" title="">Analysis 2.7</a>. However there was a high level of heterogeneity (I<sup>2</sup> = 68%; P = 0.02). There was no evidence of subgroup difference in ROSC for OHCA versus IHCA (test for subgroup differences: Chi<sup>2</sup> = 1.29, df = 1, P = 0.26, I<sup>2</sup> = 22%; <a href="./references#CD003179-fig-0016" title="">Analysis 2.7</a>). </p> <p>Three paediatric studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) compared ROSC in SDA versus HDA in 258 children and found no evidence of a difference in ROSC, but with substantial heterogeneity: RR 1.31 95% CI 0.67 to 2.56; I<sup>2</sup> = 63%; <a href="./references#CD003179-fig-0017" title="">Analysis 2.8</a>. Excluding one study (<a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) because of a high risk of bias, there was no evidence of a difference in the effect estimate for ROSC (RR 1.13, 95% CI 0.73 to 1.73; participants = 222; studies = 2; I<sup>2</sup> = 41%). There was no evidence of subgroup difference in ROSC for adults versus children; test for subgroup differences: Chi<sup>2</sup> = 0.15, df = 1 (P = 0.70), I<sup>2</sup> = 0.0%; <a href="./references#CD003179-fig-0017" title="">Analysis 2.8</a>. </p> </section> <section id="CD003179-sec-0098"> <h5 class="title">ROSC: Standard‐dose adrenaline versus vasopressin</h5> <p>The pooled estimate for the six studies ( <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) that compared SDA to vasopressin showed no evidence of a statistically significant difference in ROSC: RR 1.10, 95% CI 0.90 to 1.33; studies = 6; participants = 2531; I<sup>2</sup> = 61%; very low‐quality evidence; <a href="./references#CD003179-fig-0022" title="">Analysis 3.5</a>. There was no difference for participants who had an IHCA (RR 1.76, 95% CI 0.40 to 7.71; participants = 242, studies = 2; I<sup>2</sup> = 84%) or an OHCA (RR 1.05, 95% CI 0.80 to 1.39; participants = 1562; studies = 3; I<sup>2</sup> = 56%; <a href="./references#CD003179-fig-0023" title="">Analysis 3.6</a>). However, there was substantial statistical heterogeneity for the IHCA subgroup. There was no evidence of subgroup difference in ROSC in OHCA versus IHCA; test for subgroup differences: Chi<sup>2</sup> = 0.45, df = 1 (P = 0.50), I<sup>2</sup> = 0%; <a href="./references#CD003179-fig-0023" title="">Analysis 3.6</a>. </p> </section> <section id="CD003179-sec-0099"> <h5 class="title">ROSC: Standard‐dose adrenaline versus vasopressin plus adrenaline</h5> <p>The pooled estimate of three studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) that compared SDA versus vasopressin plus adrenaline showed no difference in ROSC: RR 0.97, 95% CI 0.87 to 1.08; participants = 3249; studies = 3; I<sup>2</sup> = 0%; low‐quality evidence; <a href="./references#CD003179-fig-0027" title="">Analysis 4.4</a>. </p> </section> </section> <section id="CD003179-sec-0100"> <h4 class="title">Other outcomes</h4> <p>We prespecified three other outcomes in our protocol (<a href="./references#CD003179-bbs2-0137" title="JacobsI , FinnJ . Adrenaline and vasopressin for cardiac arrest. Cochrane Database of Systematic Reviews2003, Issue 2. [DOI: 10.1002/14651858.CD003179] ">Jacobs 2003</a>), namely: all‐cause mortality, return of non‐perfusing rhythm, and admission to ICU, but we have not included them in the review for the following reasons. </p> <p>Firstly, all‐cause mortality is not reported in resuscitation research, since survival at specific time points (e.g. 'STHD') is the recommended outcome (<a href="./references#CD003179-bbs2-0114" title="PerkinsGD , JacobsIG , NadkarniVM , BergRA , BhanjiF , BiarentD , et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: Update of the Utstein resuscitation registry templates for out‐of‐hospital cardiac arrest. Resuscitation2015;96:328‐40. ">Perkins 2015</a>). Return of non‐perfusing rhythm was not reported by any studies. Admission to ICU was reported as an outcome by several studies (<a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>), but tended to be a surrogate for admission to hospital in OHCA. This outcome is not recommended in the Utstein guidelines (<a href="./references#CD003179-bbs2-0114" title="PerkinsGD , JacobsIG , NadkarniVM , BergRA , BhanjiF , BiarentD , et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: Update of the Utstein resuscitation registry templates for out‐of‐hospital cardiac arrest. Resuscitation2015;96:328‐40. ">Perkins 2015</a>), and we therefore have not analysed it separately. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003179-sec-0101" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003179-sec-0101">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003179-sec-0155">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003179-sec-0101"></div> <section id="CD003179-sec-0102"> <h3 class="title" id="CD003179-sec-0102">Summary of main results</h3> <p>This systematic review and meta‐analysis combines the results from 26 studies that reported the effect of administration of adrenaline or vasopressin or both on patient outcomes after cardiac arrest. We imposed no language or age limits, and the cardiac arrest could occur out of hospital (OHCA) or in the hospital (including ED or ICU) (IHCA). Because different aetiology is often involved in paediatric cardiac arrests (<a href="./references#CD003179-bbs2-0116" title="ReisAG , NadkarniV , PerondiMB , GrisiS , BergRA . A prospective investigation into the epidemiology of in‐hospital pediatric cardiopulmonary resuscitation using the international Utstein reporting style. Pediatrics2002;109(2):200‐9. ">Reis 2002</a>), we performed separate analyses for adults and children, and for IHCA and OHCA events. </p> <p>A primary outcome was survival to hospital discharge (STHD). Timely restoration of cardiac rhythm and circulation (i.e. ROSC) is essential for short‐term survival but STHD and the quality of survival are most important for patients, their families and caregivers (<a href="./references#CD003179-bbs2-0087" title="HaywoodK , WhiteheadL , NadkarniVM , AchanaF , BeesemsS , BöttigerBW , et al. COSCA (Core Outcome Set for Cardiac Arrest) in adults: an advisory statement from the International Liaison Committee on Resuscitation. Resuscitation2018;127:147‐63. ">Haywood 2018</a>). We found high‐quality evidence from two randomised controlled trials (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; 8538 participants in total) that showed that standard‐dose adrenaline (1 mg repeated doses), compared to placebo, increased STHD. By contrast, we are uncertain about STHD in studies that compare high‐dose adrenaline (HDA) and standard‐dose adrenaline (SDA), vasopressin versus SDA or vasopressin/adrenaline versus SDA, due to very low‐quality evidence. The information provided by subgroup analyses (adults versus children and IHCA versus OHCA) were limited by the small number of children and in‐hospital cardiac arrests reported. Although the analyses performed showed no evidence of a difference in STHD (primary outcome), the confidence intervals were wide. </p> <p>Survival to hospital admission (STHA) was reported less often than STHD. SDA compared to placebo more than doubled STHA. Although the analysis suggests that HDA increased STHA by 13% compared to SDA, we are uncertain about this effect, due to very low‐quality evidence. Vasopressin increased STHA by 27% compared to SDA; but the pooled effect of SDA compared to vasopressin plus SDA found no evidence for a difference between the two groups. </p> <p>Survival with a favourable neurological outcome is important for patients and their families (<a href="./references#CD003179-bbs2-0087" title="HaywoodK , WhiteheadL , NadkarniVM , AchanaF , BeesemsS , BöttigerBW , et al. COSCA (Core Outcome Set for Cardiac Arrest) in adults: an advisory statement from the International Liaison Committee on Resuscitation. Resuscitation2018;127:147‐63. ">Haywood 2018</a>), but several studies did not report neurological outcomes (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a>; <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>). Those that did used a range of methods: cerebral performance category (CPC) scores, Glasgow coma score (GCS), Glasgow outcome score, mini‐mental state examination (MMSE) and electroencephalogram (EEG) (see <a href="#CD003179-sec-0042">Primary outcomes</a> in the <a href="#CD003179-sec-0063">Included studies</a> section for more details). In the comparison of SDA to placebo, the pooled estimate did not show evidence of a difference in survival with a favourable neurological outcome (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>); however, both studies reported more participants surviving with impaired neurological outcome in the adrenaline arm. Of the four studies that compared SDA to HDA (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>) and reported CPC scores, the pooled analysis did not show any difference in neurologic outcome, but there is uncertainty around this result due to the very low quality of evidence. However. there was substantial heterogeneity (I<sup>2</sup> = 62%), with small sample sizes and wide confidence intervals, and variation in the definition of 'good' CPC scores. The five studies (<a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>;<a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) that included vasopressin in the comparison found no evidence of improved neurological outcome, but again very low‐quality evidence makes this uncertain. Hospital discharge was the most commonly collection time point for assessing neurological outcome, but longer follow‐up is needed to assess the effects of the treatments received. </p> <p>Whilst not a patient‐centred outcome (<a href="./references#CD003179-bbs2-0114" title="PerkinsGD , JacobsIG , NadkarniVM , BergRA , BhanjiF , BiarentD , et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: Update of the Utstein resuscitation registry templates for out‐of‐hospital cardiac arrest. Resuscitation2015;96:328‐40. ">Perkins 2015</a>), return of spontaneous circulation (ROSC) is commonly reported as an initial survival outcome measure in resuscitation research. Despite the different operational definitions (as shown in the <a href="./references#CD003179-sec-0122" title="">Characteristics of included studies</a> table), we include ROSC as a secondary outcome. As has been widely reported elsewhere (<a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a>; <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>), SDA increased ROSC compared to placebo. ROSC provides time to initiate therapies that may enable recovery, but the use of vasopressors could have negative effects on vital organs that may worsen neurological outcome (<a href="./references#CD003179-bbs2-0117" title="RistagnoG , TangW , HuangL , FymatA , ChangYT , SunS , et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Critical Care Medicine2009;37(4):1408‐15. ">Ristagno 2009</a>; <a href="./references#CD003179-bbs2-0122" title="SoarJ , NolanJP . Adrenaline: proven benefit in cardiac arrest at last?. Resuscitation2011;82(9):1115‐6. ">Soar 2011</a>). ROSC without good‐quality survival is a poor outcome for patients. </p> </section> <section id="CD003179-sec-0103"> <h3 class="title" id="CD003179-sec-0103">Overall completeness and applicability of evidence</h3> <p>We conducted comprehensive searches using bibliographic databases, with no limits on language or date of publication. Two Chinese papers (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) and one Japanese paper (<a href="./references#CD003179-bbs2-0054" title="NishizawaH , MiyazakiH , OgawaK , TakitaS , HashimotoK , SugiyamaM , etak . Comparison of standard‐dose epinephrine and high‐dose epinephrine in cardiopulmonary arrest outside the hospital. Kokyu to Junkan ‐ Respiration &amp; Circulation1993;41(11):1083‐7. ">Nishizawa 1993</a>) were translated into English. We also checked several systematic reviews (<a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a>; <a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a>; <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>; <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a>; <a href="./references#CD003179-bbs2-0051" title="MeyerS , McGuireW , GottschlingS , Mohammed ShamdeenG , GortnerL . The role of vasopressin and terlipressin in catecholamine‐resistant shock and cardio‐circulatory arrest in children: review of the literature. Wiener Medizinische Wochenschrift2011;161:192‐203. ">Meyer 2011</a>; <a href="./references#CD003179-bbs2-0121" title="SillbergVA , PerryJJ , StiellIG , WellsGA . Is the combination of vasopressin and epinephrine superior to repeated doses of epinephrine alone in the treatment of cardiac arrest: a systematic review. Resuscitation2008;79(3):380‐6. ">Sillberg 2008</a>; <a href="./references#CD003179-bbs2-0131" title="WyerPC , PereraP , JinZ , ZhouQ , CookDJ , WalterSD , et al. Vasopressin or epinephrine for out‐of‐hospital cardiac arrest. Annals of Emergency Medicine2006;48:86‐97. ">Wyer 2006</a>), and included in our review all studies included in these reviews that met our selection criteria. While we included 26 studies with 28 comparisons in our review, there were several groups such as IHCA and cardiac arrests in children that had too few participants or had levels of heterogeneity across studies that precluded confidence in interpretation of the pooled results. </p> <p>Furthermore, all studies in our review were conducted in relatively resource‐rich countries, with well‐established emergency medical responses, and as such may not be applicable to resource‐limited settings. Out of the 26 studies only four used a placebo (<a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>), and one of these (<a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) administered adrenaline to both groups, i.e. placebo and adrenaline were administered in the control group and 1 mg of adrenaline and 40 IU of vasopressin in the experimental group. Two of the trials of placebo versus adrenaline were challenged by the “unwillingness of providers to randomise subjects to the placebo arm" (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0025" title="WoodhouseSP , CoxS , BoydP , CaseC , WeberM . High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation1995;30(3):243‐9. ">Woodhouse 1995</a>), and <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> was subject to adverse media reporting during the conduct of the trial. </p> </section> <section id="CD003179-sec-0104"> <h3 class="title" id="CD003179-sec-0104">Quality of the evidence</h3> <p>We rated eight studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>) at low risk of bias for most categories. These include <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>, that was excluded in the <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a> systematic review for high risk of bias, and <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>, that was rated as "fair" by <a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a> because of the problems with recruitment to the study. In a sensitivity analysis, we excluded two studies (<a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>; <a href="./references#CD003179-bbs2-0020" title="SchmidbauerS , KneifelHA , HallfeldtKK . Endobronchial application of high dose epinephrine in out of hospital cardiopulmonary resuscitation. Resuscitation2000;47(1):89. ">Schmidbauer 2000</a>) for high risk of bias overall; the exclusion from pooled analyses reduced statistical heterogeneity but did not change the overall pooled result. Valid interpretation of the pooled estimate for the three paediatric studies (<a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>) was not possible, because of the substantial heterogeneity. </p> <p>We sought to compare low‐ and high‐dose adrenaline and adrenaline versus vasopressin, but study protocols varied. Some studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>) required both groups to have an initial dose of SDA before administration of the study drug. The number of doses of study drug varied from one (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>) to 15 (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>). After the number of predefined study drug doses had been administered participants often received subsequent doses of SDA as required. <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a> permitted the administration of double doses of adrenaline for the second and subsequent doses, at the physician’s discretion. <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a> allowed HDA to be administered after the initial dose of study drug. In <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>, which compared vasopressin to SDA, physicians were allowed to administer open‐label vasopressin according to medical judgement. Adrenaline was used in all other studies that allowed vasopressors after the prescribed number of study drug doses had been administered, which varied considerably between studies. </p> <p>Whilst many study protocols specified administration of the study drug as soon as practicable, in reality the time from onset of cardiac arrest to drug delivery varied widely. For example, in the large OHCA RCT of adrenaline vs placebo (<a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>), with an average response time from emergency call to scene of around six minutes (comparable to many ambulance services worldwide), the median time from call to administration of the study agent was 21 minutes (interquartile range (IQR) 16 to 27 minutes). One OHCA study (<a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>) did not allow vasopressor administration at all in the field, requiring instead that patients be randomly assigned to either vasopressin or SDA immediately after admission to the emergency room. This resulted in an interval of 30 minutes or more from call to drug administration. It is likely that the time interval from the arrest until drug administration is reduced in IHCA, since the response team is 'on site'. <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a> reported a mean time interval of 6.1 minutes to administration of study drug in their IHCA study. Similarly, <a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>, the paediatric IHCA study where most participants were in intensive care unit or the emergency department, with 78% being monitored electrocardiographically, reported a mean time interval from call to drug administration of less than three minutes. </p> <p>The differences in vasopressor administration timing and drug administration protocol can make interpretation of the specific effects of a therapy difficult when comparing outcomes between groups (<a href="./references#CD003179-bbs2-0122" title="SoarJ , NolanJP . Adrenaline: proven benefit in cardiac arrest at last?. Resuscitation2011;82(9):1115‐6. ">Soar 2011</a>). Similarly, differences in medical treatment and emergency medical services structure may affect outcomes in a RCT, e.g. the French OHCA studies (<a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>) used physician‐staffed mobile ICUs. There was therefore heterogeneity in the settings, interventions and participant populations reported in this review. This in part explains why, despite the fact that we only included randomised controlled trials, the levels of evidence quality were very low and low, increasing to high only in the adrenaline‐placebo trials. </p> <p>This review was limited to reporting randomised controlled trials. Assessment of quality of the evidence for each outcome using GRADE identified at best moderate‐quality evidence but mostly low or very low. For SDA compared to placebo, the quality of evidence was moderate for STHD, ROSC, and STHA, and low for favourable neurological outcomes (see <a href="./full#CD003179-tbl-0001">summary of findings Table for the main comparison</a>). We rated the level of evidence for SDA compared to HDA as very low for all outcomes (see <a href="./full#CD003179-tbl-0002">summary of findings Table 2</a>), with the quality of evidence downgraded for serious risk of bias, serious imprecision and serious inconsistency. We rated SDA versus vasopressin as very low quality of evidence for STHD, neurological outcome and ROSC, and low quality for STHA (see <a href="./full#CD003179-tbl-0003">summary of findings Table 3</a>), with the quality of evidence downgraded for risk of bias, very serious inconsistency and imprecision. Finally, for SDA compared to vasopressin plus adrenaline, we judged the level of evidence to be low or very low (see <a href="./full#CD003179-tbl-0004">summary of findings Table 4</a>), with the quality of evidence downgraded for serious risk of inconsistency and very serious risk of imprecision. </p> </section> <section id="CD003179-sec-0105"> <h3 class="title" id="CD003179-sec-0105">Potential biases in the review process</h3> <p>Although we performed an extensive search of the literature, we may have missed some papers reporting relevant studies. We included both OHCA and IHCA, and stratified some analyses to account for differences in outcomes because of the location of the cardiac arrest. Often only the sicker patients were included in studies, e.g. those in ventricular fibrillation (VF)/pulseless ventricular tachycardia (VT) were randomised after initial defibrillation shocks were unsuccessful (<a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>; <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). Patients with a brief duration of VF and therefore a high likelihood of survival and subsequent good neurological recovery were not included in most studies. The selection of endpoints may not be the most suitable for people who suffer a cardiac arrest. Merely having ROSC and not surviving beyond a few hours may provide the opportunity to apply post‐resuscitation care that can affect survival, but it is not a good outcome for patients if survival is of poor quality. </p> <p>Neurologic outcomes were most commonly assessed using the five‐point Cerebral Performance Category. However, the 'cut point' to define a favourable neurologic outcome varied across studies. </p> <p>Studies were published between 1991 (<a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>) and 2018 (<a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>). It is difficult to account for variations in practice over time, as well as differences between hospitals and EMS providers, which could impact on patient outcomes. </p> <p>We also cannot rule out the possibility that non‐significant trials might be less likely to be published. </p> <p>The source of funding was not stated in 11 of the 26 studies, The study drugs were provided and funded by the manufacturer in four of the 26 studies, but neither drug represents a profitable commercial option, given that they are 'off patent'. </p> </section> <section id="CD003179-sec-0106"> <h3 class="title" id="CD003179-sec-0106">Agreements and disagreements with other studies or reviews</h3> <p>Several systematic reviews (with and without meta‐analyses) have been published in the last 15 years. Some were similar to ours in that they considered a range of interventions involving adrenaline, i.e. SDA versus placebo, HDA versus SDA, or vasopressin (alone or in combination with adrenaline) versus SDA (<a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a>; <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>). Others restricted their reviews to comparisons of SDA versus vasopressin (alone or in combination with adrenaline) (<a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a>; <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a>; <a href="./references#CD003179-bbs2-0121" title="SillbergVA , PerryJJ , StiellIG , WellsGA . Is the combination of vasopressin and epinephrine superior to repeated doses of epinephrine alone in the treatment of cardiac arrest: a systematic review. Resuscitation2008;79(3):380‐6. ">Sillberg 2008</a>; <a href="./references#CD003179-bbs2-0131" title="WyerPC , PereraP , JinZ , ZhouQ , CookDJ , WalterSD , et al. Vasopressin or epinephrine for out‐of‐hospital cardiac arrest. Annals of Emergency Medicine2006;48:86‐97. ">Wyer 2006</a>; <a href="./references#CD003179-bbs2-0133" title="Xiao‐liJ , Dong‐pingW , XinI , HuiL , Xiao‐xingL , YanX , et al. Vasopressin and epinephrine versus epinephrine in management of patients with cardiac arrest: a meta‐analysis. Signa Vitae2010;5(1):20‐16. ">Xiao‐li 2010</a>). Our systematic review and meta‐analysis provides a comprehensive report of the current literature of RCTs of OHCA and IHCA, adults and paediatric studies, and comparisons of adrenaline versus placebo, standard‐dose adrenaline versus high‐dose adrenaline, and adrenaline versus vasopressin (alone and in combination with adrenaline). The following provides an overview of the differences between our systematic review and those listed above. </p> <p><a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a> included five RCTs (<a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) that compared vasopressin to adrenaline. Our review excluded <a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a> because the conference abstract was a pilot study of 10 participants from a larger RCT in progress, for which few details were provided. We could find no record of the study, and were unsuccessful in contacting the authors. The methodological quality of three studies (<a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) was rated as low risk, but <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a> was rated at high risk of bias, which differed from our assessment in which we did not rate the study as having a high risk overall. <a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a> concluded that there was no evidence of a difference in any of the outcomes (ROSC, STHA, STHD or neurological outcome) between the vasopressin and adrenaline groups. </p> <p><a href="./references#CD003179-bbs2-0131" title="WyerPC , PereraP , JinZ , ZhouQ , CookDJ , WalterSD , et al. Vasopressin or epinephrine for out‐of‐hospital cardiac arrest. Annals of Emergency Medicine2006;48:86‐97. ">Wyer 2006</a> compared vasopressin and adrenaline in cardiac arrest, but only included three RCTs (<a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>), which they regarded as "well‐reported", and referred to the <a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a> systematic review. <a href="./references#CD003179-bbs2-0131" title="WyerPC , PereraP , JinZ , ZhouQ , CookDJ , WalterSD , et al. Vasopressin or epinephrine for out‐of‐hospital cardiac arrest. Annals of Emergency Medicine2006;48:86‐97. ">Wyer 2006</a> excluded two studies (<a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a>; <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>), which were rated by <a href="./references#CD003179-bbs2-0077" title="AungK , HtayT . Vasopressin for cardiac arrest: a systematic review and meta‐analysis. Archives of Internal Medicine2005;165(1):17‐24. ">Aung 2005</a> as “low quality”. They stated that these two papers provided insufficient information about the study populations, treatment protocols, or the susceptibility to bias. We have also excluded <a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a>, as explained above. We agree with Wyer’s assessment that the inclusion of <a href="./references#CD003179-bbs2-0043" title="LeeCC , JungYS , YoonSK , KimGW , MinYG , CrupiRS , et al. Vasopressin administration in out‐of‐hospital cardiac arrest (abstract ACEP Research Forum Philadelphia). Annals of Emergency Medicine2000;36:S91. ">Lee 2000</a> in a pooled analysis "might distort the estimates in ways that the parsimoniously reported data does not allow an investigator to anticipate or assess”. However, we did not exclude any study based on risk of bias, and we have therefore included <a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>. Based on the three RCTs included in <a href="./references#CD003179-bbs2-0131" title="WyerPC , PereraP , JinZ , ZhouQ , CookDJ , WalterSD , et al. Vasopressin or epinephrine for out‐of‐hospital cardiac arrest. Annals of Emergency Medicine2006;48:86‐97. ">Wyer 2006</a>, the authors concluded that "the evidence did not show a consistent benefit of vasopressin compared to adrenaline in increasing STHD or improving neurologic outcome". </p> <p><a href="./references#CD003179-bbs2-0121" title="SillbergVA , PerryJJ , StiellIG , WellsGA . Is the combination of vasopressin and epinephrine superior to repeated doses of epinephrine alone in the treatment of cardiac arrest: a systematic review. Resuscitation2008;79(3):380‐6. ">Sillberg 2008</a> reported the results from three RCTs that compared the effect of vasopressin plus adrenaline versus repeated doses of SDA alone in OHCA (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) and IHCA (<a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>). Three excluded studies were not identified in the report. The authors did not conduct a meta‐analysis because they believed that “the three studies were too dissimilar to allow pooling of results”. However, they noted that only <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a> showed improved outcomes (ROSC, admission to hospital and STHD) for the combination of vasopressin and epinephrine (adrenaline). Our review assigns these three studies to different comparison groups, i.e. <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a> and <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a> to the 'SDA versus vasopressin' comparison, and <a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a> to the 'SDA versus adrenaline and vasopressin' comparison. </p> <p><a href="./references#CD003179-bbs2-0133" title="Xiao‐liJ , Dong‐pingW , XinI , HuiL , Xiao‐xingL , YanX , et al. Vasopressin and epinephrine versus epinephrine in management of patients with cardiac arrest: a meta‐analysis. Signa Vitae2010;5(1):20‐16. ">Xiao‐li 2010</a> compared the effect of vasopressin and adrenaline used together versus adrenaline alone in adults in cardiac arrest. They included six studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0040" title="GrmecS , MallyS . Vasopressin improves outcome in out‐of‐hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: an observational cohort study. Critical Care2006;10:R13. ">Grmec 2006</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>). One of the included studies (<a href="./references#CD003179-bbs2-0040" title="GrmecS , MallyS . Vasopressin improves outcome in out‐of‐hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: an observational cohort study. Critical Care2006;10:R13. ">Grmec 2006</a>) was an observational cohort study (not an RCT) and was therefore excluded from our review. The two studies that were excluded from the <a href="./references#CD003179-bbs2-0133" title="Xiao‐liJ , Dong‐pingW , XinI , HuiL , Xiao‐xingL , YanX , et al. Vasopressin and epinephrine versus epinephrine in management of patients with cardiac arrest: a meta‐analysis. Signa Vitae2010;5(1):20‐16. ">Xiao‐li 2010</a> review due to methodological concerns were not identified. Outcomes assessed were ROSC, STHA, survival at 24 hours, STHD and neurological outcome. <a href="./references#CD003179-bbs2-0133" title="Xiao‐liJ , Dong‐pingW , XinI , HuiL , Xiao‐xingL , YanX , et al. Vasopressin and epinephrine versus epinephrine in management of patients with cardiac arrest: a meta‐analysis. Signa Vitae2010;5(1):20‐16. ">Xiao‐li 2010</a> reported increased 24‐hour survival for the vasopressin‐plus‐adrenaline group but no evidence of a difference for the other outcomes. As explained above, we separated the adrenaline‐versus‐vasopressin studies into two distinct comparisons based on whether or not the two drugs were co‐administered. </p> <p><a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a> examined the effect of any vasopressin regimen versus adrenaline on outcomes from cardiac arrest. Eight studies (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0050" title="MentzelopoulosSD , ZakynthinosSG , TzoufiM , KatsiosN , PapastylianouA , GkisiotiS , et al. Vasopressin, epinephrine, and corticosteroids for in‐hospital cardiac arrest. Archives of Internal Medicine2009;169(1):15‐24. ">Mentzelopoulos 2009</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>; <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>) were initially selected but two were excluded (<a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>) because of a high risk of bias. <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a> was excluded because the risk of bias for blinding of long‐term outcomes was unclear, i.e. there was a lack of explicit reporting of blinding for data collectors, outcome assessors and data analysts, the estimated sample size was not reached, and the frequency of bystander CPR differed between groups. <a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a> was excluded because there was no blinding for short‐term or long‐term outcomes and there was no power calculation. We excluded neither of these studies from our review. <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a> also included <a href="./references#CD003179-bbs2-0050" title="MentzelopoulosSD , ZakynthinosSG , TzoufiM , KatsiosN , PapastylianouA , GkisiotiS , et al. Vasopressin, epinephrine, and corticosteroids for in‐hospital cardiac arrest. Archives of Internal Medicine2009;169(1):15‐24. ">Mentzelopoulos 2009</a>, which we excluded from our review because it did not allow the direct contribution of vasopressin on outcomes to be assessed. The conclusion drawn by <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a> was that "Vasopressin use in the resuscitation of cardiac arrest patients is not associated with any overall benefit or harm". </p> <p><a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a> examined the effect of vasopressors on outcomes in participants who suffered cardiac arrest. Unlike our review, <a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a> included controlled trials, meta‐analyses and case series, and is therefore not directly comparable with our review, which only includes RCTs. The only RCT included in <a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a> that was not included in our review was <a href="./references#CD003179-bbs2-0056" title="OlasveengenTM , SundeK , BrunborgC , ThowsenJ , SteenPA , WikL . Intravenous drug administration during out‐of‐hospital cardiac arrest: a randomized trial. JAMA2010;302:2222‐9. ">Olasveengen 2009</a>. This study compared the provision of advanced cardiac life support with and without intravenous drug administration, rather than comparing specific drugs. For this reason we excluded it from our review. <a href="./references#CD003179-bbs2-0094" title="LarabeeTM , LiuKY , CampbellJA , LittleCM . Vasopressors in cardiac arrest: a systematic review. Resuscitation2012;83(8):932‐9. ">Larabee 2012</a> concluded that "Epinephrine is associated with improvement in short term survival outcomes as compared to placebo, but no long‐term survival benefit has been demonstrated". </p> <p>In 2015 the International Liaison Committee for Resuscitation (ILCOR) conducted a number of systematic reviews of advanced life support interventions, including <i>Epinephrine (adrenaline) versus placebo</i> ; <i>Standard‐dose epinephrine (SDE) versus high‐dose epinephrine (HDE)</i> ; and <i>Epinephrine versus vasopressin in combination with epinephrine</i> (<a href="./references#CD003179-bbs2-0123" title="SoarJ , CallawayCW , AibikiM , BottigerBW , BrooksSC , DeakinCD , et al. Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation2015;95:e71‐120. [PUBMED: 26477429] ">Soar 2015</a>). These systematic reviews and meta‐analyses were incorporated into a single publication (<a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>). The search strategy for <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> was undertaken up until July 2013, and hence does not include the recently‐published <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> study. The inclusion criteria of the <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> review also differ from ours by restricting analyses to adult participants, thus excluding the three paediatric studies in our review (<a href="./references#CD003179-bbs2-0017" title="PerondiMB , ReisAG , PaivaEF , NadkarniVM , BergRA . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. New England Journal of Medicine2004;350(17):1722‐30. QuintanaEC . A comparison of high‐dose and standard‐dose epinephrine in children with cardiac arrest. Annals of Emergency Medicine2005; Vol. 45, issue 2:228‐9. [0196‐0644] ">Perondi 2004</a>; <a href="./references#CD003179-bbs2-0015" title="PattersonMD , BoenningDA , KleinBL , FuchsS , SmithKM , HegenbarthMA , et al. The use of high‐dose epinephrine for patients with out‐of‐hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatric Emergency Care2005;21:227‐37. ">Patterson 2005</a>; <a href="./references#CD003179-bbs2-0019" title="Sanchez‐MendiolaM , Vela‐TrejoF , Herrera‐MaldonadoN , Hernandez‐ValleA . High‐dose epinephrine does not improve survival in hospitalized pediatric critically ill patients with cardiac arrest. Critical Care Medicine1998;26(Suppl):57A. ">Sanchez‐Mendiola 1998</a>). Studies were also excluded if it was not possible to separate outcomes amongst those sustaining in‐ and out‐of‐hospital cardiac arrests, thereby excluding <a href="./references#CD003179-bbs2-0010" title="LindnerKH , AhnefeldFW , PrengelAW . Comparison of standard and high‐dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiologica Scandinavica1991;35(3):253‐6. ">Lindner 1991a</a>; <a href="./references#CD003179-bbs2-0012" title="LipmanJ , WilsonW , KobilskiS , ScribanteJ , LeeC , KrausP , et al. High‐dose adrenaline in adult in‐hospital asystolic cardiopulmonary resuscitation: a double‐blind randomised trial. Anaesthesia and Intensive Care1993;21(2):192‐6. ">Lipman 1993</a> and <a href="./references#CD003179-bbs2-0071" title="WoodhouseSP , Lewis‐DriverD , EllerH . Catecholamines during cardiopulmonary resuscitation for cardiac arrest. Resuscitation1992; Vol. 24, issue 3:263‐72. ">Woodhouse 1992</a>. We identified and translated two Chinese studies (<a href="./references#CD003179-bbs2-0009" title="LiPJ , ChenTT , ZhangJM . Clinical study on administration of vasopressin during closed‐chest cardiopulmonary resuscitation. Chinese Critical Care Medicine1999;11(1):28‐31. ">Li 1999</a>; <a href="./references#CD003179-bbs2-0026" title="ZhuHD , ZhouYS , YuXZ , ShaoX . Study of the optimal dosage of epinephrine during cardiopulmonary resuscitation. Chinese Journal of Coal Industry Medicine2000;1:54‐5. ">Zhu 2000</a>) which were not included in the <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> review and also included <a href="./references#CD003179-bbs2-0018" title="PolglaseRF , ParishDC , CampB . Prehospital administration of high‐dose epinephrine. American Journal of Emergency Medicine1994;12(6):688‐9. ">Polglase 1994</a> (Research letter), <a href="./references#CD003179-bbs2-0023" title="StiellIG , HebertPC , WellsGA , VandemheenKL , TangAS , HigginsonLA , et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet2001;358(9276):105‐9. ">Stiell 2001</a> (IHCA) and the recent <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> study. The <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> review included 14 studies for the four comparisons as follows: (1) one study for adrenaline versus placebo (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>); (2) six studies for SDA versus HDA (<a href="./references#CD003179-bbs2-0001" title="BrownCG , MartinDR , PepePE , StuevenH , CumminsRO , GonzalezE , et al. A comparison of standard‐dose and high‐dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine1992;327(15):1051‐5. ">Brown 1992</a>; <a href="./references#CD003179-bbs2-0002" title="CallahamM , MadsenCD , BartonCW , SaundersCE , PointerJ . A randomized clinical trial of high‐dose epinephrine and norepinephrine vs standard‐dose epinephrine in prehospital cardiac arrest. JAMA1992;268(19):2667‐72. ">Callaham 1992</a>; <a href="./references#CD003179-bbs2-0004" title="ChouxC , GueugniaudPY , BarbieuxA , PhamE , LaeC , DubienPY , et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation1995;29(1):3‐9. ">Choux 1995</a>; <a href="./references#CD003179-bbs2-0006" title="GueugniaudPY , MolsP , GoldsteinP , PhamE , DubienPY , DeweerdtC , et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. New England Journal of Medicine1998; Vol. 339, issue 22:1595‐601. ">Gueugniaud 1998</a>; <a href="./references#CD003179-bbs2-0021" title="ShermanBW , MungerMA , FoulkeGE , RutherfordWF , PanacekEA . High‐dose versus standard‐dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy1997;17(2):242‐7. ">Sherman 1997</a>; <a href="./references#CD003179-bbs2-0022" title="StiellIG , HebertPC , WeitzmanBN , WellsGA , RamanS , StarkRM , et al. High‐dose epinephrine in adult cardiac arrest. New England Journal of Medicine1992;327(15):1045‐50. ">Stiell 1992</a>); (3) six studies for SDA versus adrenaline plus vasopressin (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0011" title="LindnerKH , DirksB , StrohmengerHU , PrengelAW , LindnerIM , LurieKG . Randomised comparison of epinephrine and vasopressin in patients with out‐of‐hospital ventricular fibrillation. Lancet1997;349(9051):535‐7. ">Lindner 1997</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>); and (4) one study for SDA versus vasopressin alone (<a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>). Our classification of studies that fell within the 'SDA vs vasopressin alone' and the 'SDA versus adrenaline plus vasopressin' comparisons differed from those in <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>. In the 'SDA versus adrenaline plus vasopressin' comparison, we only included studies where the adrenaline and vasopressin were co‐administered (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>), whereas <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> defined their comparison of 'Adrenaline and vasopressin combination' as "the use of both drugs concomitantly during resuscitation, regardless of the order of drug administration or specific trial intervention" (<a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a>). </p> <p>With respect to the pooled analyses for each of the four comparisons: (1) <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> only included one study (<a href="./references#CD003179-bbs2-0008" title="JacobsIG , FinnJC , JelinekGA , OxerHF , ThompsonPL . Effect of adrenaline on survival in out‐of‐hospital cardiac arrest: A randomised double‐blind placebo‐controlled trial. Resuscitation2011;82(9):1138‐43. ">Jacobs 2011</a>) for the 'SDA versus placebo' comparison and is therefore not comparable with our review, which now includes the substantial recent <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a> study; (2) As in our review, <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> reported a reduced risk of ROSC for SDA compared to HDA (RR 0.85, 95% CI 0.75 to 0.97; 6 studies; 6174 participants; I<sup>2</sup>= 48%), and a small reduction in STHA for SDA compared to HDA (RR 0.87, 95% CI 0.76 to 1.00; 4 studies; 5699 participants; I<sup>2</sup> = 34%), but no difference in STHD or neurological outcomes; (3) <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> reported no difference between SDA versus adrenaline plus vasopressin for any of the outcomes (ROSC, STHA, STHD, neurological outcome); and (4) only one study (<a href="./references#CD003179-bbs2-0013" title="MukoyamaT , KinoshitaK , NagaoK , TanjohK . Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation2009;80(7):755‐61. ">Mukoyama 2009</a>) was included in the <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> 'SDA versus vasopressin alone' comparison. In contrast, (and possibly due to the difference in inclusion criteria and allocation of studies to specific comparisons) we found a small increase in STHA in favour of vasopressin compared to SDA in the pooled estimate (RR 1.27, 95% CI 1.04 to 1.54; 3 studies; 1953 participants; I<sup>2</sup> = 27%; <a href="./references#CD003179-fig-0020" title="">Analysis 3.3</a>). <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> concluded that there was "no clear advantage of SDA over placebo, HDA, adrenaline and vasopressin combination, or vasopressin alone, in STHD or neurological outcome in adults after OHCA." </p> <p><a href="./references#CD003179-bbs2-0136" title="ZhangQ , LiuB , ZhaoL , QiZ , ShaoH , AnL , et al. Efficacy of vasopressin‐epinephrine compared to epinephrine alone for out of hospital cardiac arrest patients: a systematic review and meta‐analysis. American Journal of Emergency Medicine2017;35(10):1555‐60. ">Zhang 2017</a> is the most recently published review prior to our own. It was conducted to evaluate the efficacy of vasopressin and adrenaline combined, compared to adrenaline alone in people who suffered an OHCA, with a search current to Februrary 2017. They included nine studies in the review, five of which we also include in our review (<a href="./references#CD003179-bbs2-0003" title="CallawayCW , HostlerD , DoshiAA , PinchalkM , RothRN , LubinJ , et al. Usefulness of vasopressin administered with epinephrine during out‐of‐hospital cardiac arrest. American Journal of Cardiology2006;98(10):1316‐21. ">Callaway 2006</a>; <a href="./references#CD003179-bbs2-0005" title="DucrosL , VicautE , SoleilC , LeGuenM , GueyeP , PoussantT , et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. Journal of Emergency Medicine2011;41(5):453‐9. ">Ducros 2011</a>; <a href="./references#CD003179-bbs2-0007" title="GueugniaudPY , DavidJS , ChanzyE , HubertH , DubienPY , MauriaucourtP , et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. New England Journal of Medicine2008;359(1):21‐30. ">Gueugniaud 2008</a>; <a href="./references#CD003179-bbs2-0014" title="OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department. Proceedings of Singapore Healthcare2010; Vol. 19:S96. [protect‐au.mimecast.com/s/Ld1wBRhnmzrC6W?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial‐PIVOT). Proceedings of Singapore Healthcare2011; Vol. 20, issue 1 (Supplement):50. [protect‐au.mimecast.com/s/YZ5qBxUgLpkCxz?domain=dx.doi.org] OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomised, double‐blind, multi‐centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation2012;83:953‐60. OngME , TiahL , LeongBS , TanEC , OngVY , TanEA , et al. A randomized, double‐blind multicenter trial comparing vasopressin and adrenaline in patients with cardiac arrest at the emergency department (preadmission intravenous vasopressin, adrenaline outcome trial [PIVOT]). Circulation2011;124(Suppl 21):A176. ">Ong 2012</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>), plus four Chinese studies that we did not identify in our searches (<a href="./references#CD003179-bbs2-0088" title="HeC , LiaoY , LiuF , XuD . Clinical experience from 102 cases of patients suffering from out of hospital cardiac arrest. China Modern Drugs2010;48(7):151‐2. ">He 2010</a>; <a href="./references#CD003179-bbs2-0090" title="HuJH , MaC . Combination of vasopressin. The Pre‐hospital Emergency Cardiopulmonary Resuscitation (CPR). Chinese Community Physicians2008. ">Hu 2008</a>; <a href="./references#CD003179-bbs2-0132" title="XiaoZ , HuangJ , CaiJ , FuD . Clinical research of vasopressin on patients suffering from out of hospital cardiac arrest. Lingnan Journal of Emergency Medicine2007;12(6):412‐3. ">Xiao 2007</a>; <a href="./references#CD003179-bbs2-0135" title="YangF . Clinical observation on 90 cases of patients suffering from out of hospital cardiac arrest. Chinese Foreign Medicine Research2012;10(11):46‐7. ">Yang 2012</a>). We contacted the senior author of the <a href="./references#CD003179-bbs2-0136" title="ZhangQ , LiuB , ZhaoL , QiZ , ShaoH , AnL , et al. Efficacy of vasopressin‐epinephrine compared to epinephrine alone for out of hospital cardiac arrest patients: a systematic review and meta‐analysis. American Journal of Emergency Medicine2017;35(10):1555‐60. ">Zhang 2017</a> review to clarify the citations for the four Chinese studies, who confirmed that reference 19 in this paper is incorrect, and should be <a href="./references#CD003179-bbs2-0088" title="HeC , LiaoY , LiuF , XuD . Clinical experience from 102 cases of patients suffering from out of hospital cardiac arrest. China Modern Drugs2010;48(7):151‐2. ">He 2010</a>. ROSC was the only outcome reported in <a href="./references#CD003179-bbs2-0136" title="ZhangQ , LiuB , ZhaoL , QiZ , ShaoH , AnL , et al. Efficacy of vasopressin‐epinephrine compared to epinephrine alone for out of hospital cardiac arrest patients: a systematic review and meta‐analysis. American Journal of Emergency Medicine2017;35(10):1555‐60. ">Zhang 2017</a>, with a pooled analysis that showed that vasopressin‐epinephrine was associated with a higher rate of ROSC (OR 1.67, 95% CI 1.13 to 2.49; 9 studies; 5047 participants). In contrast, in our review we did not find that the ROSC rate was increased in either of the analyses that involved vasopressin (see <a href="./references#CD003179-fig-0022" title="">Analysis 3.5</a>; <a href="./references#CD003179-fig-0027" title="">Analysis 4.4</a>). However, unlike <a href="./references#CD003179-bbs2-0136" title="ZhangQ , LiuB , ZhaoL , QiZ , ShaoH , AnL , et al. Efficacy of vasopressin‐epinephrine compared to epinephrine alone for out of hospital cardiac arrest patients: a systematic review and meta‐analysis. American Journal of Emergency Medicine2017;35(10):1555‐60. ">Zhang 2017</a>, we distinguished between studies that compared vasopressin versus adrenaline (see <a href="./references#CD003179-fig-0022" title="">Analysis 3.5</a>) and those that compared vasopressin plus adrenaline versus adrenaline (see <a href="./references#CD003179-fig-0027" title="">Analysis 4.4</a>). It is therefore not surprising that there was very high heterogeneity (I<sup>2</sup> = 83%) in the pooled estimate in the <a href="./references#CD003179-bbs2-0136" title="ZhangQ , LiuB , ZhaoL , QiZ , ShaoH , AnL , et al. Efficacy of vasopressin‐epinephrine compared to epinephrine alone for out of hospital cardiac arrest patients: a systematic review and meta‐analysis. American Journal of Emergency Medicine2017;35(10):1555‐60. ">Zhang 2017</a> meta‐analysis for ROSC. </p> <p>As described in the Results (Outcomes) section above, we chose to use the amended denominator where loss to follow up for different outcomes (e.g. neurological status) was described (e.g. <a href="./references#CD003179-bbs2-0016" title="PerkinsG , QuinnT , DeakinCD , NolanJP , LallR , SlowtherA , et al. Pre‐hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC‐2): trial protocol. Resuscitation2016;108:75‐81. PerkinsGD , JiC , DeakinCD , QuinnT , NolanJP , ScomparinC , et al. A randomized trial of epinephrine in out‐of‐hospital cardiac arrest. New England Journal of Medicine2018;379(8):711‐21. ">Perkins 2018</a>; <a href="./references#CD003179-bbs2-0024" title="DiSG , NineC , CatalanoHN , WenzelV , KrismerAC , ArntzHR , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. Prensa Medica Argentina2005; Vol. 92, issue 10:641‐3. [0032‐745X] WenzelV , KrismerAC , ArntzHR , SitterH , StadlbauerKH , LindnerKH , et al. A comparison of vasopressin and epinephrine for out‐of‐hospital cardiopulmonary resuscitation. New England Journal of Medicine2004;350(2):105‐13. ">Wenzel 2004</a>). There is therefore some discrepancy in the denominators used in analyses described in other systematic reviews. For example, similar to our review, the <a href="./references#CD003179-bbs2-0103" title="MentzelopoulosSD , ZakynthinosSG , SiemposI , MalachiasS , UlmerH , WenzelV . Vasopressin for cardiac arrest: Meta‐analysis of randomized controlled trials. Resuscitation2012;83(1):32‐9. ">Mentzelopoulos 2012</a> review used 'adjusted' denominators, but this was not done in the <a href="./references#CD003179-bbs2-0098" title="LinS , CallawayCW , ShahPS , WagnerJ D , BeyeneJ , ZieglerCP , et al. Adrenaline for out‐of‐hospital cardiac arrest resuscitation: A systematic review and meta‐analysis of randomized controlled trials. Resuscitation2014;85(6):732‐40. ">Lin 2014</a> review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003179-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Selection process" data-id="CD003179-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Selection process</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003179-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003179-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.8 ROSC (adults vs children)." data-id="CD003179-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.8 ROSC (adults vs children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.1 Survival to hospital discharge." data-id="CD003179-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), outcome: 2.1 Survival to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 1 Survival to hospital discharge." data-id="CD003179-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 1 Survival to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 2 Survival to hospital admission." data-id="CD003179-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 2 Survival to hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 3 Neurological outcome." data-id="CD003179-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 3 Neurological outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 4 ROSC." data-id="CD003179-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Standard dose adrenaline (SDA) versus placebo, Outcome 4 ROSC.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 1 Survival to hospital discharge." data-id="CD003179-fig-0010" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 1 Survival to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 2 Survival to hospital discharge (adult vs child)." data-id="CD003179-fig-0011" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 2 Survival to hospital discharge (adult vs child). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 3 Survival to hospital discharge (OHCA vs IHCA)." data-id="CD003179-fig-0012" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 3 Survival to hospital discharge (OHCA vs IHCA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 4 Survival to hospital admission." data-id="CD003179-fig-0013" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 4 Survival to hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 5 24‐hour survival." data-id="CD003179-fig-0014" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 5 24‐hour survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 6 Neurological outcome." data-id="CD003179-fig-0015" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 6 Neurological outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 7 ROSC (OHCA vs IHCA)." data-id="CD003179-fig-0016" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 7 ROSC (OHCA vs IHCA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-002-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 8 ROSC (adults vs children)." data-id="CD003179-fig-0017" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Standard dose adrenaline (SDA) versus high dose adrenaline (HDA), Outcome 8 ROSC (adults vs children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 1 Survival to hospital discharge." data-id="CD003179-fig-0018" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 1 Survival to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 2 Survival to hospital discharge (OHCA vs IHCA)." data-id="CD003179-fig-0019" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 2 Survival to hospital discharge (OHCA vs IHCA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 3 Survival to hospital admission." data-id="CD003179-fig-0020" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 3 Survival to hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 4 Neurological Outcome." data-id="CD003179-fig-0021" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 4 Neurological Outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 5 ROSC." data-id="CD003179-fig-0022" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 5 ROSC.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 6 ROSC (OHCA vs IHCA)." data-id="CD003179-fig-0023" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Standard dose adrenaline (SDA) versus vasopressin, Outcome 6 ROSC (OHCA vs IHCA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 1 Survival to hospital discharge." data-id="CD003179-fig-0024" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 1 Survival to hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 2 Survival to hospital admission." data-id="CD003179-fig-0025" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 2 Survival to hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 3 Neurological Outcome." data-id="CD003179-fig-0026" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 3 Neurological Outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003179-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/urn:x-wiley:14651858:media:CD003179:CD003179-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_t/tCD003179-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 4 ROSC." data-id="CD003179-fig-0027" src="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Standard dose adrenaline (SDA) versus [adrenaline and vasopressin], Outcome 4 ROSC. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/media/CDSR/CD003179/image_n/nCD003179-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003179-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to placebo for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to placebo for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest <br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention:</b> standard‐dose adrenaline (SDA)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.44<br/> (1.11 to 1.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8538<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/> (25 to 42) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.51<br/> (1.67 to 3.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8489<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000<br/> (139 to 313) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.21<br/> (0.90 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8535<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes were defined as a CPC score of &lt; 3 or mRS &lt; 4</p> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (17 to 30) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.86<br/> (2.21 to 3.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8663<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>115 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>329 per 1000<br/> (254 to 427) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category; <b>mRs:</b> modified Rankin score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as one study at high risk of bias for incomplete outcome data </p> <p><sup>b</sup>Downgraded by one level for imprecision. The CI crosses the clinical decision threshold. </p> <p><sup>c</sup>Downgraded one level as two studies at high risk of bias for incomplete outcome data </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to placebo for cardiac arrest</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003179-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to high‐dose adrenaline (HDA) for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to high‐dose adrenaline (HDA) for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest<br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention:</b> High‐dose adrenaline (HDA)<br/> <b>Comparison:</b> Standard‐dose adrenaline (SDA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline (SDA)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with high‐dose adrenaline (HDA)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.10<br/> (0.75 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6274<br/> (10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Two more studies (N = 245) reported no survivors in either arm, but could not be added to the meta‐analysis due to zero events. </p> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>36 per 1000<br/> (24 to 53) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/> (1.03 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5764<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>213 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000<br/> (220 to 264) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.91<br/> (0.65 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5803<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,d,f,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes were defined as a CPC score of &lt; 3 in two studies; CPC &lt; 2 in one study and CPC &lt; 4 in one study. </p> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000<br/> (17 to 32) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.15<br/> (1.02 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7014<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>303 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>349 per 1000<br/> (309 to 391) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The funnel plots were slightly asymmetrical, so downgraded one level for possible publication bias.<br/> <sup>b</sup>Downgraded one level as five studies at high risk of bias.<br/> <sup>c</sup>Downgraded one level for inconsistency. Setting (in, out of hospital, emergency department) varies between studies. Variation in route of administration, doses and timing of dose administration between studies.<br/> <sup>d</sup>Downgraded one level for imprecision. Confidence interval includes possibility of clinically important harm or benefit.<br/> <sup>e</sup>Downgraded one level as three studies at high risk of bias.<br/> <sup>f</sup>Downgraded one level as two studies at high risk of bias.<br/> <sup>g</sup>Downgraded one level for inconsistency, due to substantial statistical heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to high‐dose adrenaline (HDA) for cardiac arrest</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003179-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to vasopressin for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to vasopressin for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest<br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention: V</b> asopressin<br/> <b>Comparison:</b> Standard‐dose adrenaline (SDA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vasopressin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25 (0.84 to 1.85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2511<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90 per 1000<br/> (60 to 133) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.27<br/> (1.04 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1953<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA (ED)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>260 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 per 1000<br/> (270 to 400) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.82<br/> (0.54 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2406<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes were defined as a CPC score of &lt; 3</p> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/> (21 to 49) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.10<br/> (0.90 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2531<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA and IHCA</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>311 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1000<br/> (280 to 413) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as two studies at high risk of bias.<br/> <sup>b</sup>Downgraded two levels for inconsistency. Studies included in‐ and out‐of‐hospital cardiac arrest and cardiac arrests in the emergency department. Inclusion criteria varied between studies, with inconsistencies in interventions given.<br/> <sup>c</sup>Downgraded two levels for imprecision. Events less than 300, upper and lower CI limits include both meaningful benefit and harm.<br/> <sup>d</sup>Downgraded one level for imprecision. Upper and lower CI limits include both meaningful benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to vasopressin for cardiac arrest</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003179-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to SDA plus vasopressin for cardiac arrest</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Standard‐dose adrenaline (SDA) compared to SDA plus vasopressin for cardiac arrest</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people suffering cardiac arrest<br/> <b>Setting:</b> either outside of hospital (OHCA) or during hospitalisation (IHCA)<br/> <b>Intervention:</b> SDA plus vasopressin<br/> <b>Comparison:</b> Standard‐dose adrenaline (SDA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard‐dose adrenaline (SDA)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with SDA plus vasopressin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.76<br/> (0.47 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3242<br/> (3 RCTs)<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000<br/> (11 to 29) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Survival to hospital admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.83 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3249<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>218 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>207 per 1000<br/> (181 to 236) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.65<br/> (0.33 to 1.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2887<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Favourable neurological outcomes was defined as a CPC score of &lt; 3</p> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9per 1000<br/> (5 to 18) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return of spontaneous circulation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.87 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3249<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OHCA only</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>299 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000<br/> (260 to 323) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CPC:</b> cerebral performance category </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision. Event rate less than 300 and confidence interval includes possibility of clinically important harm or benefit.<br/> <sup>b</sup>Downgraded one level for inconsistency. Setting (in, out of hospital, emergency department) varies between studies. Variation in route of administration, doses and timing of dose administration between studies.<br/> <sup>c</sup>Downgraded one level for imprecision. Confidence interval includes possibility of clinically important harm or benefit. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Standard‐dose adrenaline (SDA) compared to SDA plus vasopressin for cardiac arrest</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/full#CD003179-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003179-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Standard dose adrenaline (SDA) versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Survival to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [1.11, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Survival to hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.51 [1.67, 3.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neurological outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.90, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 ROSC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8663</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [2.21, 3.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Standard dose adrenaline (SDA) versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003179-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard dose adrenaline (SDA) versus high dose adrenaline (HDA)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Survival to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.75, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Survival to hospital discharge (adult vs child) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.75, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5957</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.73, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.17, 13.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Survival to hospital discharge (OHCA vs IHCA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.74, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 OHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.72, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 IHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.42, 3.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Survival to hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [1.03, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 24‐hour survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.76, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neurological outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5803</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.65, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 ROSC (OHCA vs IHCA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.06, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 OHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [1.06, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 IHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [0.82, 3.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 ROSC (adults vs children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [1.02, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 ROSC‐adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [1.01, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 ROSC‐children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.67, 2.56]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard dose adrenaline (SDA) versus high dose adrenaline (HDA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003179-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Standard dose adrenaline (SDA) versus vasopressin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Survival to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.84, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Survival to hospital discharge (OHCA vs IHCA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.84, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 OHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.76, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 IHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.29, 17.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Survival to hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1953</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.04, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neurological Outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.54, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 ROSC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2531</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.90, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 ROSC (OHCA vs IHCA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.84, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 OHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.80, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 IHCA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.40, 7.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Standard dose adrenaline (SDA) versus vasopressin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003179-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Standard dose adrenaline (SDA) versus [adrenaline and vasopressin]</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Survival to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.47, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Survival to hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neurological Outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 ROSC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Standard dose adrenaline (SDA) versus [adrenaline and vasopressin]</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003179.pub2/references#CD003179-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003179.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003179-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003179-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003179-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD003179-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD003179-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003179\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003179\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003179\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003179\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003179\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003179.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003179.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003179.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003179.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003179.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718223047"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003179.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718223051"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003179.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcb110f69f3fd',t:'MTc0MDcxODIyMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 